ISSN: 2329-6631

Journal of Developing Drugs
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year
across USA, Europe & Asia with support from 1000 more scientific Societies and
Publishes 700+ Open Access Journals which contains over 50000
eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers
Each Journal is getting 25,000+ Readers
This Readership is 10 times more when compared to other
Subscription Journals (Source: Google Analytics)
 
 
 
 
 
 
 

Editorial Board

Yavuz S Silay

Editor-in-Chief
Yavuz S Silay
Director
Therapeutic Medical Head
Teva Neurosciences Commercial Organization
USA
 

Biography :

Dr. Silay is an Executive Physician Scientist, certified Clinical Research Professional in the Pharmaceutical industry with an Executive MBA degree from the Oline Business School at Washington University in St. Louis which is ranked #2 by Wall Street Journal. Dr. Silay is a member of American Academy of Neurology, DIA (Drug Information Association) SIAC’s for Good Clinical Practice/Quality Assurance Special Interest Activity Community (GCP/QA SIAC), Clinical Trial Registry/Results Disclosure Working Group (CTR/RD Working Group), Natural Health Products, MDS (Movement Disorder Society) current chair of TABID (Turkish American Business Improvement Council) for Healthcare and Pharmaceutical Industry, Charter and previous president of AMSA (American Medical Student Association) Turkey and previous president of SOCRA (Society of Clinical Research Associates) in New Jersey. Dr. Silay, a permanent resident of U.S.A. was born in Turkey and educated in Turkey, Germany and U.S.A. He completed his medical school from The University of Ankara in Turkey and his internship at Baylor College of Medicine and University of Texas in Houston, Texas. He was trained in a Physician Scientist Training Program at The MD Anderson Cancer Center of University of Texas. As a prolific scientific writer he published extensively with more than 15 peer reviewed article and more than 50 platform and abstract presentation at the academic and industry level in national and international meetings. Dr. Silay joined Teva Neuroscience on May 2009 and is currently the Head of Clinical and Medical Parkinson’s franchise as the Director of Scientific Affairs and Medical Research in U.S Headquarter in Kansas City reporting to Chief Medical Officer and VP of Medical Affairs. He is also responsible for the Parkinson’s disease Investigator Initiated Trials, Phase IIIB, Phase IV trials and for developing relationships with Key Opinion Leaders in the field of Neurology. He gained experience in therapeutic areas within pulmonary critical care, transplant, CNS and rheumatologic conditions such as, Fibromyalgia, Alzheimer, MS, Epilepsy, Autism and Parkinson’s disease.

 Biography
Research Interest :

Clinical development and medical affairs experience and interest in Internal Medicine (Pulmonary & Critical care, Asthma, CF, Sarcoidosis, Lung transplant Diabetic Neuropathy), Neurology (Movement disorders, Parkinson′s Huntington′s, Tourette, Alzheimer, DBS, Botox, Autism, Epilepsy, Head trauma), Psychiatry (Schizophrenia, Bipolar), Rheumatology, Pain (Fibromyalgia, Osteoarthritis), CFS, GI (anti emetics), Growth Hormone, Hematology, Oncology, Women′s health.

 Research Interest
 Network
 Acceptance Letter
Walter J Lukiw

Executive Editor
Walter J Lukiw
Associate Professor
Department of Ophthalmology
Louisiana State University
USA
 

Biography :

Dr. Walter J. Lukiw, Associate Professor, Neuroscience and Ophthalmology, LSU Neuroscience Center and Department of Ophthalmology, Louisiana State University Health Sciences Center, School of Medicine, US.

 Biography
Research Interest :

Alzheimer’s disease, Bioinformatics, Brain gene transcription, Chromatin structure, Complexity, DNA polymorphisms, Environmental health, Genetic evolution, Genotoxicity, Inflammation, Memory, Neurodegeneration, Neurological disorders, Neurotoxicity, Messenger RNA, Micro RNA (miRNA), Oxidative stress, Prion diseases, Sleep cycles, Small RNA, Trace metals.

 Research Interest
 Network
Ritu Aneja

Executive Editor
Ritu Aneja
Associate Professor
Department of Biology
Georgia State University
USA
 

Biography :

Ritu Aneja, Associate Professor in the Department of Biology from Georgia State University. She has done her PhD from University of Delhi in 1997. She completed her MS(Gold medalist) in chemistry from University of Delhi. She is Adjunct Associate Professor, Tuskegee University, AL and Adjunct Associate Professor, Center for Cancer Research and Therapeutic Development (CCRTD), Clark Atlanta University. She got Post-Doctoral Fellow trainings from Department of Cell Biology, Emory University and Department of Internal Medicine, Yale University.

 Biography
Research Interest :

Cytoskeletal Microtubules, Cell Cycle and Cancer.

 Research Interest
 Network
Syed AA Rizvi

Executive Editor
Syed AA Rizvi
Assistant Professor
Department of Pharmaceutical Sciences
Nova Southeastern University
USA
 

Biography :

Dr. Rizvi pursued an M.S and Ph.D combined degree program at the Center for Biotechnology and Drug Design, Department of Chemistry, Georgia State University (GSU), Atlanta, GA. While working at GSU, Dr. Rizvi was trained in the areas of Analytical Chemistry, Separation Sciences, Bioanalysis, Surfactant Chemistry, Chiral Separations of the Drugs, Trace Level Analysis (Forensic Chemistry) of Drugs in human body fluids (led to a US and International patent). Right after finishing M.S and Ph.D at the GSU, Dr. Rizvi pursued another Ph.D (under Prof. Martin J. D’Souza) at the College of Pharmacy and Health Sciences, Department of the Pharmaceutical Sciences, Mercer University (MU), Atlanta, GA in collaboration with Dr. Scott L Childs (founder and chief Scientific officer, Renovo Research, LLC). At Mercer, Dr. Rizvi was trained in the areas of Solid Dosage Formulations (direct compressed tablets), Controlled Release Formulations, Nanoparticulate System for Non-Invasive real time In Vivo Imaging, Cell-Lipid interaction Studies. At Renovo, Dr. Rizvi was trained in the area of Solid State Chemistry of the Drugs, e.g., Polymorphism and Cocrystallization. Moreover, Dr. Rizvi pursued part time postdoctoral research in the laboratory of Dr. Fredric M. Menger (Charles Howard Candler Professor) at the Sanford S. Atwood Chemistry Center, Emory University, where he polished his skills in Organic Synthesis, Soft Material Chemistry, Surface and Interfacial Sciences, Gene Transfection Studies using Gemini Surfactants, State of the art, Langmuir-Adam Balance Studies. Dr. Rizvi has published many peer-reviewed articles (cited over 600 times) in top ranking journals and two book chapters. Dr. Rizvi publications include one of the most highly rated article, two cover articles and one figure from Dr. Rizvi’s paper was included in the text book “Quantitative Chemical Analysis” by Daniel C. Harris (7th Edition, p 616, W. H. Freeman, 2006, ISBN-10: 0716770415). Dr. Rizvi also presented his work through posters and oral presentations in national and international conferences. Dr. Rizvi also serves as editor-in-chief, the editorial board member of several scientific journals and review papers for more than 20 different journals. Dr. Rizvi enjoys teaching and engaging students in thought process, beside creative cooking at home and practicing martial arts.

 Biography
Research Interest :

Micro and Nano-Technology for Drug Delivery, Controlled Release Formulations, Solid State Chemistry of the Drugs, Surface Chemistry, Analytical Chemistry, Soft Material Chemistry, Forensic Chemistry, Organic Chemistry, Natural Product Chemistry, Vaccinology and Immunology.

 Research Interest
 Network
 Acceptance Letter
Robert Lubran

Robert Lubran
Director
Division of Pharmacologic Therapies
Center for Substance Abuse Treatment
Substance Abuse and Mental Health Services Administration
USA
 

Biography :

Dr. Lubran has been directing the Substance Abuse and Mental Health Services Administration (SAMHSA) Division of Pharmacologic Therapies since 1997. Under his leadership, SAMHSA has given responsibility for regulatory oversight and certification of more than 1,250 opioid addiction treatment centers treating in excess of 300,000 patients daily; implements the 2000 Drug Addiction Treatment Act resulting in the approval of more than 20,000 physicians to prescribe buprenorphine for the treatment of opioid dependence; published clinical guidelines on Managing Chronic Pain in Adults with or in Recovery from Substance Use Disorders and Medication Assisted Treatment for Opioid Addiction in Opioid Treatment Programs; provided grants to State Prescription Drug Monitoring Programs under the National All Schedules Prescription Electronic Reporting Act; supports the Federation of State Medical Boards efforts to update The Model Policy for the Use of Controlled Substances for the Treatment of Pain (2004). Prior to coming to SAMHSA in 1989, Mr. Lubran managed medical quality assurance, utilization management and peer review activities in the Department of Veterans Affairs Office of Quality Management. His other Federal assignments include positions with the National Institute of Mental Health and the Bureau of Health Planning and Resources Development. Before joining Federal service, Mr. Lubran was an analyst with the Mission Neighborhood Health Center in San Francisco, CA and the Executive Director of the Jefferson County Alcohol and Drug Abuse Center in Steubenville, Ohio. Mr. Lubran has advanced degrees in Public Administration from Golden Gate University, San Francisco, CA and Urban Affairs from Cleveland State University, Cleveland, OH. He is a graduate of Miami University, Oxford, Ohio.

 Biography
Research Interest :

Buprenorphine for the treatment of opioid dependence, Opioid Addiction, Prescription Drug Monitoring Programs.

 Research Interest
 Network
 Acceptance Letter
Gloria L Matthews

Gloria L Matthews
Senior Scientific Director
Head of Orthopaedic/Regenerative Medicine Research & Biomedical Imaging
Genzyme Corporation
USA
 

Biography :

Dr. Gloria Matthews is a Senior Scientific Director and Head of Orthopaedic/Regenerative Medicine Research and Biomedical Imaging at Genzyme Corporation, headquartered in Cambridge, Massachusetts (USA). She is board certified in equine orthopaedic surgery, and after finishing her surgical residency at Tufts University in 1997, Gloria completed an NIH-National Research Service Award-funded PhD program at Cornell University, focusing on cell and molecular biology of osteoarthritis. Her post-doctoral work at Cornell University included research in the areas of cartilage repair and developmental diseases of joints, as well as time spent as a visiting scientist at University of Rochester Medical Center’s Department of Orthopaedics and Rehabilitation. Prior to joining Genzyme, Gloria spent several years in private and university equine surgical practice, and continues to work periodically with regional equine hospitals on a consulting basis. For the past nine years at Genzyme, she has been expanding the work of her internal orthopaedic research group focusing on osteoarthritis and focal cartilage defect repair by leveraging collaborations with internal and external partners in an effort to solve the preclinical and clinical challenges of osteoarthritis therapeutic development, targeting both pain and disease modification.

 Biography
Research Interest :

Orthopaedic Surgery, Joint Disease, Imaging, Product Development, Osteoarthritis, Regenerative Medicine, Cartilage Repair, Orthobiologics, Translational Medicine/Clinical Science.

 Research Interest
 Network
Jair C Soares

Jair C Soares
Professor
Department of Psychiatry and Behavioral Sciences
University of Texas Medical School
USA
 

Biography :

Jair C. Soares, Professor and Chairman, Department of Psychiatry and Behavioral Sciences, University of Texas Medical School, Houston and Executive Director, Harris County Psychiatric Center. He has edited or co-edited three textbooks, has published over 120 peer-reviewed articles and book chapters in psychiatric literature, and he co-edited the peer-review journal “Bipolar Disorders-An International Journal of Psychiatry and Neurosciences”.

 Biography
Research Interest :

Soares has extensive clinical research experience in the field of mood disorders, as well as brain imaging modalities and neurocognitive methods to investigate the pathophysiology of bipolar disorder and the mechanisms of action of pharmacological treatments.

 Research Interest
 Network
Anas Younes

Anas Younes
Professor
Department of Cancer Medicine
The University of Texas MD Anderson Cancer Center
USA
 

Biography :

Anas Younes, MD, is Professor of Medicine, University of Texas MD Anderson Cancer Center and Director of Clinical and Translational Research at the Department of Lymphoma and Myeloma at MD Anderson. He received his degree-granting education from The University of Damascus School of Medicine, Damascus, Syria, MD, 1983, Medicine. He has done Postgraduate Training from Guest Researcher, Endocrine and Reproductive Research Branch (ERRB), NICHD, National Institutes of Health, Bethesda.

 Biography
Research Interest :

Younes’ clinical and translational research is focused on the development of novel targeted therapy for patients with Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL) including T-cell lymphoma. He is a member of the NCI Lymphoma Steering Committee and serves on several scientific editorial boards and NIH Study sections. His laboratory is supported by a P50 SPORE grant on lymphoma.

 Research Interest
 Network
Hector O Ventura

Hector O Ventura
Professor
Department of Medicine
Tulane University
USA
 

Biography :

Hector O. Ventura, MD, is the Assistant DIO, Graduate Medical Education Committee and the Section Head, Cardiomyopathy and Heart Transplant Center at the Ochsner Clinic Foundation, New Orleans, Louisiana. He is also a Professor, Cardiology, University of Queensland School of Medicine, Ochsner Clinical School, Brisbane, Australia as well as a Professor of Medicine at the Tulane University School of Medicine in New Orleans. He completed an internship and residency at the Central Military Hospital in Buenos Aires, followed by research fellowships in arterial hypertension and cardiovascular diseases, an internship, and an internal medicine residency at the Ochsner Medical Institutions in New Orleans.

 Biography
Research Interest :

Arterial hypertension following cardiac transplantation, the effect of digitalis on mortality in heart failure, Lipid profiles after cardiac transplantation.

 Research Interest
 Network
 Acceptance Letter
Michaela Higgins

Michaela Higgins
Department of Medicine
Massachusetts General Hospital Cancer Center
USA
 

Biography :

Michaela Higgins attended medical school at University College Dublin in her native Ireland. She completed her residency in Dublin and trained for two years as a fellow in Medical Oncology in Ireland before moving to the USA and completing a 3 year fellowship in Medical Oncology at Johns Hopkins Hospital, Baltimore, Maryland. She was awarded an American Society of Clinical Oncology Young Investigator Award in 2009 and served as Chief Fellow in Medical Oncology during her last year at Johns Hopkins. Dr. Higgins currently serves as an Attending Physician with the Breast Cancer Program at Massachusetts General Hospital, Boston.

 Biography
Research Interest :

Breast cancer (with special interest in hormone-receptor-positive breast cancer), Endocrine therapy for breast cancer, Bone-modulating agents and bone metastases, Novel drugs for breast cancer, Chemoprevention.

 Research Interest
 Network
Kenneth Maiese

Kenneth Maiese
Professor
Department of Neurology and Neurosciences
New Jersey Health Sciences University
USA

Biography :

Kenneth Maiese is Professor and Head of Cellular and Molecular Signaling at New Jersey Health Sciences University. Dr. Maiese has been fortunate to receive recognition with outstanding teaching awards and election to America′s Top Physicians, the Best of U.S. Physicians, and Top Doctors. His investigations are designed to translate basic science into successful therapeutic treatments for conditions such as cancer, metabolic disorders, cardiovascular disease, diabetes, stroke, and Alzheimer′s disease. He is a top cited author with continuous funding from the American Diabetes Association, the American Heart Association, the Bugher Foundation, a Johnson and Johnson Focused Giving Award, and the NIH. Dr. Maiese holds several patents, has over 300 publications and has authored 5 books. Dr. Maiese also serves as the Editor-in-Chief, Associate Editor, or editorial board member for more than 60 journals as well as on multiple executive committees, technology panels, and scientific advisory councils.

 Biography
Research Interest :

Translational drug development, Oxidative stress, Cell signaling, Transcription factors, Apoptosis, Autophagy

 Research Interest
 Network
Patricia L Darbishire

Patricia L Darbishire
Associate Professor
College of Pharmacy
Purdue University
USA

Biography :

Patti Darbishire is a Clinical Associate Professor of Pharmacy Practice and Director for the Introductory Pharmacy Practice Experience Program at Purdue University. She teaches pharmacy practice, research-based independent study and experiential courses in the professional pharmacy program. She is a Service-Learning faculty fellow, faculty fellow with the Purdue Center for Instructional Excellence, and an active member of the American Association of Colleges of Pharmacy. She is an editorial board member for two peer-review journals, has published 18 peer reviewed articles on medications, disease states and experiential program development. She regularly gives national, state, and local presentations to pharmacists, healthcare providers and community organizations. Dr. Darbishire has received numerous awards and grants including Purdue Preceptor of the Year, assessment and engagement grants, as well as a HRSA grant to develop a comprehensive geriatric education program

 Biography
Research Interest :

Darbishire has developed clinical programs in community practice, ambulatory care, hospice care, and with underserved populations. Her research interests include medication management, community pharmacy operations, patient education and counseling, medication error prevention, medication adherence, as well as assessment methods and learning outcomes. She holds state and national certifications in several practice areas, including pharmaceutical care, diabetes management, and Medicare.

 Research Interest
 Network
Michael F Wempe

Michael F Wempe
Associate Research Professor and Director
Department of Pharmaceutical Sciences
School of Pharmacy
University of Colorado Denver
USA

Biography :

Wempe is aPhysical/Synthetic Organic Chemist (PhD) with Chemical and Pharmaceutical work experience.His laboratory uses chemical synthesis (organic and bio-organic) to produce known and novel compounds which are subsequently screened (in vitro and in vivo) for biological activity; his laboratory conducts fundamental research in drug development (metabolism, pharmacokinetics, and toxicity). Research activities include: i) Medicinal Chemistry - rational drug design and Structure-Activity Relationship (SAR) elucidation; ii) computational chemistry; iii) developing novel technology to improve oral bioavailability of small molecules; and iv) bio-analytical methodology development.There are a variety of research activities occurring within his laboratory;two major efforts include the development of LAT1 selective inhibitors for use in cancer research and therapy, and another involves the development of URAT transporter inhibitors in the development of novel cardiovascular agents. Dr. Wempe is the Director of the Medicinal Chemistry Core facility at the University of Colorado, Anschutz medical campus.

 Biography
Research Interest :

Research activities include: i) Medicinal Chemistry - rational drug design and Structure-Activity Relationship (SAR) elucidation; ii) computational chemistry; iii) developing novel technology to improve oral bioavailability of small molecules; and iv) bio-analytical methodology development

 Research Interest
 Network
Igor Astsaturov

Igor Astsaturov
Department of Medical Oncology
Fox Chase Cancer Center
USA
 

Biography :

Igor Astsaturov, Assistant member from Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia. He has done Internship and Residency in Internal Medicine, Good Samaritan Hospital, Baltimore, MD and PhD in Hematology/Oncology, Russian Hematological Research Center, Moscow.

 Biography
Research Interest :

Intrinsic and acquired cellular resistance limits the efficacy of EGFR targeted cancer therapeutics. Rational and more efficacious combinations of targeted therapeutics, siRNA screening to comparatively probe the signaling network for proteins that regulate the effectiveness of both targeted (EGFR being the prime target) and chemotherapeutic agents, New synergistic targets with EGFR antagonists as a direct path to clinical exploitation of study results including distal sterol biosynthesis pathway metabolic enzymes such as SC4MOL and NSDHL using cellular systems and an animal model of conditional NSDHL deficiency. Explorations of new metabolic targets for cancer therapy involving these previously unexplored sterol pathway genes.

 Research Interest
 Network
Emmanuel Andres

Emmanuel Andres
Professor
Department of Internal Medicine
University of Strasbourg
France

Biography :

In 1996, Dr Andrès received his MD degree in Internal Medicine, at the University Of Strasbourg, France. He worked as an associated professor in the University Hospital of Strasbourg, France. In 1998 he worked as PhD in Molecular Biology in the Laboratory of Professor Hoffmann (2011, Nobel Prize of Medicine) in the field of cationic antimicrobial peptides and pathogens - host relations. In 2002, he was nominated Professor at the University of Strasbourg, France. He also was in the head of an Internal Medicine Department (of >60 beads) in the University hospital of Strasbourg, France. He was awarded the French Society of Haematology, price for research in the field of anaemia related to cobalamin or folate deficiencies in 2004. Achievements include development of research in: all type of anaemia, neutropenia and thrombocytopenia, particularly drug-induced neutropenia and agranulocytosis or thrombocytopenia; haematopoietic growth factors; and cobalamin deficiencies. His recent works also include research and development on human sounds analysis, electronic stethoscope, e-auscultation, and e-medicine. In that function he was recruited as advisor to several pharmaceutical companies or start-up. In 2007, He was nominated in the French National Commission of Pharmacovigilance.

 Biography
Research Interest :

Development of an electronic stethoscope "intelligent" and basic research and clinical auscultation human.
Development work and research projects in the field of telemedicine and the contribution of new technologies to support chronic disease and old age (COPD, diabetes, Alzheimer′s...).
Clinical research activity in Internal Medicine and Hematology with the following themes: anemia, neutropenia and agranulocytosis drug, idiopathic thrombocytopenic purpura, research activity in the field of Metabolism including deficiencies in vitamin B12.
Clinical research activity on Orphan Diseases Developing a biobank of samples from the body of people with common pathologies complex (BIOMAX).

 Research Interest
 Network
Ignazio Olivieri

Ignazio Olivieri
Director
Department of Lucania
San Carlo Hospital of Potenza
Italy
 

Biography :

Ignazio Olivieri is Director of the Rheumatology Department of Luciana, San Carlo Hospital of Potenza and Madonna delle Grazie Hospital of Matera, Italy. He gained his medical degree in 1978 from the University of Pisa Medical School and in 1983 became a certified specialist in Rheumatology. Following years of research on seronegative spondyloarthropathy and Behçet’s disease at the Rheumatic Disease Unit at the University of Pisa followed by the Rheumatic Disease Unit, Policlinico S.Orsola-Malpighi in Bologna, Dr. Olivieri took his current position as Consultant Rheumatologist in 1998. He is a member of the American College of Rheumatology, the Assessment in Ankylosing Spondylitis (ASAS) group and the Group on Psoriasis and Psoriatic Arthritis (GRAPPA) study group. In addition, he is on the editorial board on of The Journal of Rheumatology and the annual supplement on Behçet’s Disease and Familial Mediterranean Fever published in Clinical and Experimental Rheumatology. Dr. Olivieri is widely published having authored over 280 articles in peer-reviewed publications.

 Biography
Research Interest :

Ankylosing spondylitis, Undifferentiated spondyloarthritis, Psoriatic arthritis and Behçet’s disease.

 Research Interest
 Network
Niraldo Paulino

Niraldo Paulino
Professor
Department of Pharmacology
Universidade Bandeirante de São Paulo
Brazil
 

Biography :

Niraldo Paulino is Professor at Universidade Bandeirante de São Paulo and Chief Research and Development of BIOMED Group in the Pharmacy Program. He received his pharmaceutical degree from the Universidade Federal de Santa Catarina, Florianópolis, SC Brazil and completed his doctor degree at the same university in collaboration with Ludwig Maximilian University in Germany. He has experience in Pharmacology, focusing on medicinal plants pharmacology, molecular pharmacology and cellular signaling. The special area of interest is: medicinal plants (Brazilian species). propolis, inflammation, and molecular mechanisms of action of natural products and bioactive synthetics. He has several publications and patent and is one of the leading research experts in the Brazilian propolis and its actions and applications. He serves on various review committees including Chef-Editor in Revista de Pesquisa e Inovação Farmacêutica in Brazil.

 Biography
Research Interest :

The special area of interest is: medicinal plants (Brazilian species). propolis, inflammation, and molecular mechanisms of action of natural products and bioactive synthetics.

 Research Interest
 Network
 Acceptance Letter
Antonio Russo

Antonio Russo
Professor
Department of Surgical and Oncological Sciences
University of Palermo
Italy
 

Biography :

Dr. Antonio Russo received his MD from University Medical School of Palermo, Italy in 1982. His post-graduate speciality were Medical Genetic and Medical Oncology. Since 2008, he is Associate Professor of Medical Oncology and Chief of Genetic and Molecular Oncology Unit at University Medical School of Palermo. Since 2004, he is an Adjunct Associate Professor Temple University’s, Philadelphia USA and since 2011, he is an Adjunct Full Professor Temple University, Philadelphia, USA. He is Expert member of INSERM, INCA, NWCRF. The central theme of his studies is translational and clinical research, meaning the application of molecular genetics in routine malignant tumors. He is author for more than 200 publications in top-rated cancer journal.

 Biography
Research Interest :

Design and conduction of phase II-III clinical trials in solid tumours, Chemotherapy and targeted therapies of solid tumors, Prognostic and predictive biomolecular indicators of therapeutic response to monoclonal antibodies and to tyrosine kinase inhibitors in solid tumours, Molecular genetics, prevention and therapies of hereditary and familial tumors especially those of the breast/ovary and of the gastrointestinal tract.

 Research Interest
 Network
Carlo Enrico Traverso

Carlo Enrico Traverso
Professor
Department of Neuroscience
University of Genova
Italy

Biography :

Carlo E. Traverso received his MD degree from the University of Genova Medical School, where he also attended the Residency program under Professor Mario Zingirian. He attended the Wills Eye Hospital in Philadelphia, for subspecialty training in Glaucoma with George L. Spaeth, MD and in Cornea with Peter Laibson, MD (1981-1983), and King Khaled Eye Specialist Hospital in Riyadh where he worked for 3.5 years (1985-1988). He has been since at the University Eye Clinic in Genova, Present position: Director of Residency Program in Ophthalmology. Chairman of Clinica Oculistica, Department of Neurosciences, Ophthalmology and Genetics, University of Genova-Azienda Ospedaliera Universitaria “San Martino”. Medical Director of Melvin Jones Eye Bank of Genova. Member of the Executive Committee of the European Glaucoma Society (EGS) as President.

 Biography
Research Interest :

Glaucoma, Cornea, Cataract, Health Ecomomics.

 Research Interest
 Network
Daniele Santini

Daniele Santini
Associate Professor
Department of Medical Oncology
Policlinico Universitario
Italy
 

Biography :

Daniele Santini, Associate Professor, Department of Medical Oncology, Policlinico Universitario, ItalyUniversity “La Sapienza”, Rome, Italy. He graduated cum laude Medicine and Surgery degree from University La Sapienza, Rome, Italy, Graduated cum laude Resident-Specialty in Medical Oncology, PhD in Immunopharmacology.

 Biography
Research Interest :

Design and conduction of phase II-III clinical trials in solid tumours, Chemotherapy in gastrointestinal tumors, Molecular mechanisms on tumor progression, Molecular prognostic and predictive factors in gastrointestinal tumors, Role of bisphosphonates and emerging target theraphies in Osteoncology (denosumab, Src inhibitors, Catepsine K inhibitors, Endothelin A inhibitors, Wnt/dkk agonist/antagonists, TGF beta inhibitors, etc.) Molecular Factors predictive of response to monoclonal antibodies and to tyrosine kinase inhibitors in solid tumours (EGFR inhibitors, Multitarget TKis, Antiangiogenic drugs, mTOR inhibitors, etc).

 Research Interest
 Network
Massimo Serra

Massimo Serra
Chief of Pharmacogenomics and Pharmacogenetics
Laboratory of Experimental Oncology
Orthopaedic Rizzoli Institute
Italy
 

Biography :

Massimo Serra got the Degree in Biological Sciences (score of 110 out of 110, with high honours). Since 1989, he is employed as Staff Researcher (Biologo Dirigente I Livello) at the Laboratory of Experimental Oncology of the Orthopaedic Rizzoli Institute, I.R.C.C.S.(Bologna, Italy). He also worked abroad as Research Fellow at the "Molecular Genetics Laboratory" (Salk Institute, San Diego, CA) in 1993 and as Research Fellow at the "Cytogenetics and Molecular Genetics Laboratory" of the University of Helsinki (Finland) in 1997. From 1999 to 2008, he has been the Chief of the "Drug Resistance" Research Unit (Modulo Organizzativo), which was upgraded to the "Pharmacogenomics and Pharmacogenetics" Research Unit (Struttura Semplice) on 2009, at the Laboratory of Experimental Oncology of the Orthopaedic Rizzoli Institute. From 1998 to 2008, he has been member of the Scientific Committee of the Orthopaedic Rizzoli Institute and of the Directive Committee of the Musculo-Skeletal Oncology, department of the Orthopaedic Rizzoli Institute. Since 2009, he is member of the Direction Committee of the Orthopaedic Rizzoli Institute.

 Biography
Research Interest :

•Analysis of the genetic and molecular mechanisms responsible for drug resistance in the most common bone and soft-tissue sarcomas, as well as on the genetic background associated with a differential drug sensitivity in osteosarcoma.
•Pharmacogenomic and pharmacogenetic characterisation of the most common musculoskeletal tumours, with particular regard to osteosarcoma.
•Analysis of genetic and molecular mechanisms responsible for resistance to doxorubicin, methotrexate and cisplatin in human osteosarcoma cells.
Preclinical validation of candidate prognostic and therapeutic markers in osteosarcoma and other bone tumor patients.
•Preclinical evaluation of the efficacy of new target-specific drugs and innovative therapeutic approaches for osteosarcoma and analysis of their interactions with conventional chemotherapeutic drugs and regimens.

 Research Interest
 Network
 Acceptance Letter
Warren P Mason

Warren P Mason
Associate Professor
Department of Medicine
University of Toronto
Canada
 

Biography :

Mason is the medical director of the largest multidisciplinary treatment centre for brain tumors in Canada. In addition to his clinical and research activities at the Princess Margaret Hospital, He is also the chair of the brain disease site group of the NCIC Clinical Trials Group. Dr. Mason graduated in medicine from the University of Toronto, and completed residences in Internal Medicine and Neurology at the University of Toronto and McGill University, Montreal. He received fellowship training in neurooncology at Memorial Sloan-Kettering Cancer Center in New York.

 Biography
Research Interest :

Development of medical therapies for primary brain tumors.

 Research Interest
 Network
Ofer Agid

Ofer Agid
Department of Psychiatry
University of Toronto
Canada
 

Biography :

Ofer Agid, Assistant Professor of Psychiatry-Department of Psychiatry, University of Toronto. He has completed B. Med Sc. from Hebrew University, Jerusalem, Israel. MD from Medical School of Hadassah, Hebrew University, Jerusalem, Israel. He is presently appointed as a Clinical Chief in first episode division, schizophrenia Program, Centre for Addiction and Mental Health. (Since 2010) Medical Leader-Home Intervention for Psychosis team, schizophrenia Program, Centre for Addiction and Mental Health.

 Biography
Research Interest :

Schizophrenia, First episode, Antipsychotics, Trajectory of response.

 Research Interest
 Network
Donat Koegel

Donat Koegel
Head of Experimental Neurosurgery
Department of Neurosurgery
Frankfurt University
Germany
 

Biography :

Donat Kögel is currently the Head of the Section of Experimental Neurosurgery at the Goethe-University Hospital in Frankfurt. His research focuses on the molecular events leading to gliomagenesis, as well as apoptosis deficiency and therapy resistance of glioblastoma multiforme, the most malignant and deadly human primary brain tumor. Currently, his research focuses on investigating novel genetic insight-based therapeutic strategies for the treatment of gliomas in cell culture models and in transplantable syngeneic animal tumor models. Another major aim in Donat Kögel´s lab is to identify the relevant pathophysiological stress stimuli and apoptotic signalling pathways implicated in apoptotic neuron death in stroke, Alzheimer´s disease and Parkinson´s disease. Here, he has made important contributions to decipher the molecular mechanisms underlying neuronal cell death, the transcriptional responses to pathophysiological stress in neurons, and neuroprotective signalling pathways modulated by lesion-induced cytokines in the brain.

 Biography
Research Interest :

Mechanisms of programmed cell death, Acute and chronic cns damage, Neuronal stress signalling, Physiological and pathophysiological roles of the amyloid precursor protein and its family members, Mitochondrial control of cell death, Target-specific therapies for the treatment of brain tumors, Oncogenic signalling pathways, Autophagy in health and disease, Mechanisms of tumor cell migration and invasion.

 Research Interest
 Network
Michael Beck

Michael Beck
Professor
Department for Lysosomal Storage Disorders
University of Mainz
Germany
 

Biography :

Michael Beck, Professor of Children Hospital from University of Mainz, Germany Education and Scientific Training, Pediatrics, Genetics, Biochemistry. He is Head of the Department for Lysosomal Storage Disorders at the Children Hospital University of Mainz (Villa Metabolica). He has given presentations at International Meetings. Over 100 presentations were given at various scientific international meetings. He got memberships of Societies, Deutsche Gesellschaft für Kinderheilkunde, Deutsche Gesellschaft für Humangenetik, SSIEM (Society for the Study of Inborn Errors of Metabolism), ESPR (European Society for Paediatric Research), ESGLD (European Study Group on Lysosomal Diseases), ASHG (American Society Human Genetics). He has more than 200 publications, mostly in peer-reviewed international journals Mainz, August 8, 2011.

 Biography
Research Interest :

Pediatrics, Metabolic disorders, Lysosomal storage disorders, Genetics, Orphan disease.

 Research Interest
 Network
Klaus Podar

Klaus Podar
Associate Professor
University of Heidelberg
Germany
 

Biography :

Klaus Podar, MD degree from the Medical University of Vienna, his MSc. from the University of Vienna/Faculty of Life Sciences, and his PhD from the University of Vienna/Faculty of Life Sciences and Harvard Medical School, where he joined the Faculty in 2004. In 2009 Dr. Podarmoved to the NCT, University of Heidelberg and DKFZ, where he accepted the position of a hematologist/oncologist and research group leader. Dr. Podar has presented numerous lectures at both national and international meetings; has published more than 100 peer-reviewed scientific articles, educational book chapters, and state-of-the-art reviews both in basic as well as clinical research; is the recipient of numerous awards; member of professional societies including ASH, AACR, and EHA; and serves on the editorial board of several scientific journals. His lab investigates signal transduction pathways within the tumor microenvironment (e.g. multiple myeloma), which support tumor cell survival, proliferation, migration and drug resistance.

 Biography
Research Interest :

Signal transduction, Tumor microenvironment, Cell migration, Cell proliferation, Tumor cel survival, Tumor angiogenesis, Novel targeted therapies.

 Research Interest
 Network
Daniel Alexander Beyer

Daniel Alexander Beyer
Professor
Department of Obstetrics and Gynaecology
Schleswig-Holstein University
Germany
 

Biography :

Daniel Alexander Beyer is a Senior Consultant Physician and Head of department of Gynaecological Colposcopy and Cervical Dysplasia, Department of Obstetrics and Gynaecology, Division of Reproductive Endocrinology and Infertility at Schleswig-Holstein University, Germany. He has done his MD and BS from Saarland University Medical School, Germany.

 Biography
Research Interest :

Cervical colposcopy and dysplasia, Gynaecological laparoscopic surgery, Reproductive medicine and gynaecological endocrinology, Kisspeptine, Vitrifikation of 2PN zygotes, Clinical research concerning: reproductive medicine and follow-up risk pregnancies.

 Research Interest
 Network
Tadeusz Robak

Tadeusz Robak
Professor
Department of Hematology
Medical University of Lodz
Poland
 

Biography :

Dr. Tadeusz Robak is presently working as Professor of Hematology at the Medical University of Lodz and since 1997 he is Head of the Department of Hematology, at the Medical University and Copernicus Memorial Hospital in Lodz, Poland. He studied medicine at Medical University of Lodz and obtained his approval as hematologist in 1985 and clinical pharmacologist in 1987. In addition, he undertook further postgraduate training at Hammersmith Hospital and Royal Postgraduate Medical School in London. In 1996-2002 he was vice-rector and rector of the Medical University of Lodz. Professor Robak is a chairmen of the CLL subgroup of the Polish Adult Leukemia Study Group. He has written more than 500 journal articles 450 abstracts and 18 books or chapters. His special interests are on the application of nucleoside analogs and monoclonal antibodies in the treatment of leukemia and lymphoma. Professor Robak is involved in many translational research projects and was the principal investigator for several clinical trials of new drugs in leukemia, lymphoma and multiple myeloma. Prof. Tadeusz Robak has been selected by the World Scientists Forum for "Eminent Scientist of the year 2010" International Award in the field of Hematology-Oncology based on his research.

 Biography
Research Interest :

Preclinical and clincal studies of nucleoside analogs and monoclonal antibodies in leukemia and lymphoma.

 Research Interest
 Network
Paraskevi Papaioannidou

Paraskevi Papaioannidou
Professor
Department of Pharmacology
Aristotle University of Thessaloniki
Greece

Biography :

Paraskevi Papaioannidou is a professor of Pharmacology in Medical Faculty of the Aristotle University of Thessaloniki, Greece. She graduated in Chemistry and Medicine at the Aristotle University of Thessaloniki, and she has a PhD in Pharmacology. She had a post-graduate education in the University of Alberta, Canada, and a post-doctoral education in Unicam Laboratories, Cambridge, UK. She has a long academic career in the Aristotle University of Thessaloniki, she was the first tutor and organizer of courses in Pharmacology in the newly-established University of Thessaly, Greece, and she was a visiting researcher in the University of Bologna and the University of Novi Sad, Serbia. She has a considerable collaboration in international research projects (including collaboration with ΝΙΗ, Bethesda, USA), she has created two European research networks (Follicle net and AntibioSurv) and she is the organizer and leader of the international research project ASPPOC. She is evaluator of the Greek Ministry of Education on European Research Projects, member of the Committee on European Educational Programs of the Aristotle University of Thessaloniki, reviewer and member of the Editorial Board of peer-review scientific journals, and organizer of International and Greek scientific Congresses. Currently she is a member of the Board of Directors of DOATAP (Hellenic NARIC), a member of the Executive Committee of the Greek Society of Pharmacology, and Vice-President of “Saint-George” (the Association of people from Korissos).

 Biography
Research Interest :

Antimicrobial Chemotherapy – Reproductive Pharmacology – Gender related Pharmacology – Environmental Pharmacology – Prostaglandins – Drug Interactions

 Research Interest
 Network
Hisham Ibrahim

Hisham Ibrahim
Professor
Department of Biochemistry & Biotechnology
Kagoshima University
Japan
 

Biography :

Dr. Hisham R. Ibrahim is currently a Professor of Biochemistry and Structural Biology at Kagoshima University (Japan). He obtained his Master degree in Biochemistry from Yamaguchi University (Japan) in 1990, and PhD degree in Structural Biology and Protein Engineering from Tottori University (Japan) in 1993. He then become a Research Group Leader in Taiyo Kagaku Research Center (Mie, Japan) and carried out research on developing immune molecules against infectious diseases. In 1995, he became Assistant Professor at Kagoshima University, and pursued a research fellowship in the Center for Antimicrobial Research (CAR), California State Polytech University, Los Angeles (USA). He was appointed as Associate Professor in 2001, and become a Professor of Structural Biology at the Department of Biochemistry & Biotechnology in 2010. He is a Conference Developing Member and Chairman in the American Chemical Society (ACS) as well as in the American Oil Chemists Society (AOCS), and serves as reviewer in over 12 reputable journal of biological chemistry, drug design and drug delivery.

 Biography
Research Interest :

The research focuses on the discovery and design of bio-active peptides and proteins with therapeutic potential for the treatment of infectious diseases, cancers, inflammation and oxidative stress related diseases. The work involves uncovering the molecular mechanisms of bio-active proteins and peptides as a means of developing novel therapeutics and biomedical applications. Other research focus relates mainly to the development of novel drug-delivery system for specific targeting of water-insoluble drugs into their intracellular targets or intracellular infective pathogens by utilizing physicochemical and biological properties of proteins and peptides. A research with a view to explore a novel therapeutic potential of bio-active polypeptides as novel drug targeting molecule for the treatment of complicated human diseases.

 Research Interest
 Network
Noritaka Kawada

Noritaka Kawada
Department of Geriatric Medicine and Nephrology
Osaka University Graduate School of Medicine
Japan
Read Interview session with Noritaka Kawada

Biography :

Dr. Noritaka Kawada did his MD in Osaka University School of Medicine, Japan in 1992, and has received his PhD in Osaka University Graduate School of Medicine, Japan in 1999. He was a Research Assistant Professor in Center for Hypertension and Renal Disease Research, Georgetown University, USA from 2003 to 2006. Currently, he is an Assistant Professor in Osaka University Graduate School of Medicine, Japan.

 Biography
Research Interest :

Kidney disease, Hemodialysis, and renal transplantation. The pathological role of hyperuricemia. Intervention of tissue fibrosis and inflammation. Renal physiology, including renal hemodynamic and electrolyte transport, Hypertension, related to renin-angiotensin system and prostaglandins.

 Research Interest
 Network
Q Ping Dou

Q Ping Dou
Professor
Departments of Oncology, Pharmacology and Pathology
Wayne State University
USA
 

Biography :

Q. Ping Dou is Professor of Oncology, Pharmacology and Pathology and Co-Program Leader of Developmental Therapeutics Program and Scientific Leadership Council Member, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI. He obtained his B.S. degree in chemistry from Shandong University in 1981, PhD degree in chemistry from Rutgers University in 1988, and postdoctoral training at the Dana-Farber Cancer Institute and Harvard Medical School from 1988 to 1992 (Mentor: Arthur B. Pardee). He has extensive experience in the fields of drug discovery, chemoprevention, natural products, proteasome inhibitors, cell cycle and apoptosis. He has published ~190 peer-reviewed research and review articles, many of those in journals of the highest quality, and also holds ~10 patents. He has extensive experience in professional service, including various study sections, several advisory and editorial boards, and committees. He has mentored numerous graduate students, post-doctoral fellows and junior faculty.

 Biography
Research Interest :

Discovering molecular targets of natural products in pre-clinical studies, Validation in targeted cancer intervention clinical trials, Proteasome inhibitors rapidly induce tumor cell apoptosis, Tea polyphenols and medicinal compounds potently and specifically inhibit the chymotrypsin-like activity of the proteasome in vitro and in vivo at physiological concentrations.

 Research Interest
 Network
 Acceptance Letter
Deepak Bhatia

Deepak Bhatia
Department of Pharmaceutical sciences
Northeast Ohio Medical University 
USA

Biography :

Deepak Bhatia, Ph.D. is an Assistant professor in the department of pharmaceutical sciences at Northeast Ohio Medical University and an adjunct professor in the School of Biomedical Sciences at Kent State University. Dr. Bhatia received his M.S. and Ph.D. in pharmaceutical and pharmacological sciences from West Virginia University followed by post-doctoral fellowship from City of Hope in the department of stem cells and leukemia research. During his Ph.D. he received fellowship form National Institute of Occupational Safety and Health (NIOSH). His current research is in the area of DNA damage signaling and chemoprevention. He serves as an ad-hoc reviewer for many journals and as editorial board member of international journal of pharmaceutical engineering. Dr. Bhatia also serves as an onsite evaluator for Higher Learning Commission.

 Biography
Research Interest :

The broad focus of my research is to investigate genetics and epigenetics changes in human lung cancer in response to genotoxic stress. Occupational exposure to mammalian cells elicit a variety of stress-related signals that lead to the altered expression of multiple genes involved in cell-cycle control, programmed cell death, and in some case DNA repair. Interestingly, key growth-control genes, such as the tumor suppressors p53 and RB and transcription factors such as Egr-1, Nf-kB, play central roles in some of these signaling pathways, and perturbations in their function in many human tumor cells have important implications in carcinogenesis. More interestingly, micro RNAs are also suggested to be involved in the regulating these genes that may act as oncogenic or tumor suppressor gene. Therefore, we aim to understand their function upon stress and ultimately use such genes and gene products as molecular genetic tools to employ novel "gene therapy" for the treatment of malignancies notably lung cancer. •Genetic and epigenetic changes in lung cancer upon genotoxic stress – microRNA regulation, cell cycle check points, histone methylation

•Chemo-preventive mechanism of dietary agents
•Free Radical Biology - Role of reactive oxygen and nitrogen species in cancer •Drug Delivery- functionalized nanoparticles and liposomes drug carriers for siRNA and miRNAs

 Research Interest
 Network
John L Zhou

John L Zhou
Professor
Department of Applied Sciences
London South Bank University
UK

 

Biography :

John L. Zhou, Professor, Department of Applied Sciences, London South Bank University, UK. Since obtaining his 1st degree in environmental engineering in 1986, John Zhou has been pursuing his research in the UK with a master and PhD degree at Manchester University. He has taught at the University of Wales Bangor and University of Sussex, before becoming Professor of Environmental Engineering at London South Bank University in 2010. He has published over 80 articles in international journals, and acted as an expert assessor for various funding bodies including the EU’s framework programmes and the US National Science Foundation.

 Biography
Research Interest :

Biogeochemistry and ecotoxicology of organic contaminants in natural environment, Environmental analytical chemistry involving novel method development and applications, Characterisation of natural waters and particles and their relation to contaminant fate, Water and wastewater treatment by physical, chemical and biological processes, Production, transport and impact of atmospheric pollutants, Contaminated land and sediments.

 Research Interest
 Network
Partha P Banerjee

Partha P Banerjee
Associate Professor
Department of Biochemistry and Molecular & Cellular Biology
Georgetown University Medical Center
Washington
USA

Biography :

Partha Banerjee is an Associate Professor in the Department of Biochemistry and Molecular & Cellular Biology and Member of Lombardi Comprehensive Cancer Center at Georgetown University Medical Center, Washington DC. He received B. Sc. in Zoology Honors from the University of Calcutta, India; M. Sc. in Life-Science and Ph. D. in Endocrine Biochemistry from Visva-Bharati University, Santiniketan, India. Dr. Banerjee did his postdoctoral training from Johns Hopkins University, Baltimore, USA. He is a recipient of visiting scientist fellowship from the National Science Council, Government of Taiwan, American Federation of Aging Research Award, Department of Defense New Investigator Award and several NIH R01 awards. He serves as an Associate Editor of Journal of Carcinogenesis, and editorial board members of The Open Prostate Cancer Journal, World Journal of Clinical Oncology, Journal of Cancer Research & Therapy. He serves as a scientific reviewer for DOD and NIH study sections and reviewers for 25 leading cancer journals. His research focuses on an epigenetically silenced tumor suppressor gene, RASSF1A, regulation of androgen receptor signaling and non-canonical function of telomerase reverse transcriptase in prostate cancer.

 Biography
Research Interest :

His research focuses on an epigenetically silenced tumor suppressor gene, RASSF1A, regulation of androgen receptor signaling and non-canonical function of telomerase reverse transcriptase in prostate cancer.

 Research Interest
 Network
Apollina Goel

Apollina Goel
Department of Radiation Oncology
University of Iowa
USA
 

Biography :

Dr. Goel is currently an Assistant Professor in the Free Radical and Radiation Biology Program within the Department of Radiation Oncology at the University of Iowa, USA. Dr. Goel received her undergraduate degree in Biotechnology from Pune University, India. She pursued her doctorate in Biotechnology at Institute of Microbial Technology, India. Dr. Goel then undertook post-doctoral studies at University of Nebraska Medical center and at Mayo Clinic, USA. During her postdoctoral research at UNMC, she developed a radioimmunotherapy approach to the treatment of solid tumors. Subsequently she spent two years at Mayo Clinic studying the interactions between genes and transcription factors. During her next two years at Mayo clinic, Dr. Goel combined her basic and translational experience in multiple myeloma and non-Hodgkins lymphoma models. Dr. Goel is currently pursuing targeted radiotherapy (using bone-seeking radiotherapy and oncolytic viruses encoding for human sodium iodide symporter gene) with molecular drugs to target these B-cell malignancies. Dr. Goel has published more than 25 papers in reputed journals, and authored several review articles and book chapters. She is serving as grant reviewer for several agencies and scientific reviewer for several journals.

 Biography
Research Interest :

Chemo-radiotherapy for hematological malignancies, Understanding and circumventing resistance to radiotherapy in multiple myeloma and B-cell lymphoma.

 Research Interest
 Network
Sidharth Chopra

Sidharth Chopra
Centre for Infectious Disease and Biodefense Research
Stanford Research Institute International
USA
 

Biography :

Dr. Sidharth Chopra is a Research Scientist in Center for Infectious disease and Biodefense Research at SRI International (2008-present). He was a Stanford University Medical Centre post-doctoral fellow (2004-08) where he received a Novozymes fellowship to conduct research in drug discovery for MDR tuberculosis. He worked with Prof. Anand Ranganathan at International Center for Genetic Engineering and Biotechnology (ICGEB) from 2000-04 for pursuing his doctoral degree in Microbial Biotechnology. He has received B.S and M.S. in Microbiology from University of Delhi, India. He is the recipient of CSIR-UGC fellowship to pursue doctoral studies at ICGEB. He regularly reviews articles from Journal of Clinical Microbiology, Journal of Antimicrobial Chemotherapy among others.

 Biography
Research Interest :

Tuberculosis, Non tuberculous mycobacteria, Staphylococcus, Acinetobacter baumannii, Drug resistance and novel drug discovery.

 Research Interest
 Network
Alfredo E Rodriguez

Alfredo E Rodriguez
Director
Head Cardiac Unit
Otamendi Hospital
Buenos Aires
Argentina

Biography :

Dr. Alfredo E. Rodriguez, MD, PhD, Cardiovascular Research Centre (CECI), Head of Cardiology Department at Otamendi Hospital, Argentina. He presented at an international breakfast symposium that was dedicated to current experiences with drug-eluting balloons (DEB).

 Biography
Research Interest :

Diabetes
Cardiology
Hemodynamics

 Research Interest
 Network
 Acceptance Letter
Bhuvnesh K Sharma

Bhuvnesh K Sharma
Senior Director (Translational Research)
ScyTek Laboratories, Inc.
205 South 600 West
Logan,UT
 

 

Biography :

Bhuvnesh K. Sharma, PhD is a Senior Director R&D (Translational Oncology) at ScyTek Laboratories Inc., a premier Medical Biotech Co. in Logan UT. He also holds appointment as Consultant, Celprogen Inc.,Torrance, CA. He earned his MS and PhD degrees from India. He did his Post-Doctoral trainings in Molecular Oncology at St. Marys Hospital Medical School, London, UK and Johns Hopkins University Medical Institutions, Baltimore, MD. Dr.Sharma has previously served as Adjunct Asso.Professor,Georgetown Univ. School of Medicine Washington DC; Senior Scientist, Weinberg Cancer Institute MedStar Health Franklin Square Medical Center, Baltimore, MD; Deputy Director of a National Cancer Institute,N.Delhi, India; Visiting Scholar, Johns Hopkins University School of Hygiene & Public Health, Baltimore, MD; Visiting Scientist, Univ.of Maryland School of Medicine Dept of Pharmacology & Expt. Therapeutics, Baltimore, MD. Dr.Sharma is the recipient of prestigious Sandoz (now Novartis ) Oration award & distinguished honors for his discoveries on Predictive Cancer biomarkers aimed at rational designing of novel cancer immunotherapeutic. He has published numerous articles on Cancer biomarkers and conducted research reviews on emerging cancer vaccines and prospects of tumor-specific adjuvant immunotherapy in Human metastatic melanoma. He is a noted expert in Melanoma stem cell research and their prospects in targeted therapeutics. Dr.Sharma is also serving as an editorial board member of prestigious journals in Biomedicine/ Oncology .

 Biography
Research Interest :

His current interest is centered on Translational Oncology with main emphasis on Identification of novel targets in Cancer Stem cells, Validation of targeted cancer therapeutics, nanomedicine and drug development program.

 Research Interest
 Network
Carsten H Meyer

Carsten H Meyer
Professor
Department of Ophthalmology
University of Bonn
Switzerland
 

Biography :

Dr. Carsten H. Meyer, MD, is a specialist in vitreo-retinal diseases. He went to medical school in Freiburg (Germany), Innsbruck (Austria), and Oxford (England) and obtained his medical degree from the University of Munich, Germany. Dr. Meyer completed his residency at the University Eye Hospital Luebeck, Germany and persued 1999 a 2 year vitreo-retinal research fellowship at the Duke Eye Center, Duke University in Durham. He returned to Germany and became an Assistant Professor at the Department of Ophthalmology, Philipps-University, Marburg, Germany. He was appointed at the Department of Ophthalmology, University of Bonn in 2006 and became a Professor of Ophthalmology in 2007. He is a board member of several ophthalmic journals and serves as a reviewer in more than 40 peer-reviewed journals. As of 2011 he became the head of the Department of Ophthalmology, Pallas Clinic, Olten, Switzerland.

 Biography
Research Interest :

Imaging vitreo-retinal structures and novel treatments of age-related macular degeneration.

 Research Interest
 Network
Josep M Argil�s

Josep M Argilés
Professor
Department of Biochemistry & Molecular Biology of Cancer
University of Barcelona
Spain

Biography :

Dr. Josep M. Argilés obtained his Doctorate from the University of Barcelona in 1981. He then became Lecturer in Biochemistry and carried out postdoctoral work on acetone metabolism in mammals. In 1987 he undertook further postdoctoral training in the Laboratory of Metabolism and Molecular Biology at the National Institutes of Health, Bethesda, Maryland. in 1988, he became interested in the modulation of the host response by and went to the Metabolic Research Laboratory, radcliffe Infirmary, Oxford, UK to work on the metabolic effects of tumour necrosis factor and other cytokines. At present he is Professor of Biochemistry and Molecular biology at the Faculty of Biology, University of Barcelona, Spain being the leader of a research group interested in cancer cachexia.

 Biography
Research Interest :

Cancer cachexia

 Research Interest
 Network
Ngai Sai Ming

Ngai Sai Ming
Professor
Department of Biology
School of Life Sciences
The Chinese University of Hong Kong
Hong Kong
 

Biography :

Professor NGAI Sai Ming is presently working in Department of Biology; Molecular Biotehnology; Cell and Molecular Biology Program.He recieved his PhD from University of Alberta, Canada in 1994.In 1986, he did his B.Sc. (Hons) in Biochemistry from University of Waterloo, Canada.He has worked as and Associate Professor for School of Life Sciences.He also worked as Director for The Chinese Medicinal Fungal Proteomics Laboratory, CUHK and as an Investigator, State Key Laboratory for Agrobiotechnology, CUHK.

 Biography
Research Interest :

Bioinformatics and Proteomics
Protein/peptide structural and functional studies
Research and development on Modern Chinese Medicine

 Research Interest
 Network
Chi-Chiu Mok

Chi-Chiu Mok
Department of Medicine
Tuen Mun Hospital
Hong Kong
 

Biography :

Dr. Mok is the Chief of Rheumatology in the Department of Medicine, Tuen Mun Hospital and Center for Assessment and Treatment of Rheumatic Diseases at Pok Oi Hospital, Hong Kong. He is also the President of the Hong Kong Society of Rheumatology. Dr. Mok is the principal investigator of a number of clinical trials of novel biological agents in systemic lupus erythematosus, rheumatoid arthritis and glucocorticoid-induced osteoporosis. In addition, Dr. Mok is the core editorial member of a number of international journals in Rheumatology and is the adhoc reviewer of more than 50 Rheumatology and General Medical Journals. He has reviewed more than 279 clinical papers and 6 grant applications.

 Biography
Research Interest :

Systemic lupus erythematosus in particular lupus nephritis, Rheumatology, Nephrolog, Diagnosis and management of various rheumatic diseases.

 Research Interest
 Network
Gamal Abdul Hamid Al-Alawi

Gamal Abdul Hamid Al-Alawi
Associate Professor
Department of Hematology/Oncology
Faculty of Medicine
University of Aden
Yemen

Biography :

Prof Dr med Gamal Abdul Hamid has received his PhD in hematology-oncology from faculty of medicine (Caral Gustav Carus),University of Dresden during the period of 1988- 1993. Currently , he is working as director of Aden Oncology Center and head of hematology and clinical laboratory in Faculty of Medicine, University of Aden. He has successfully completed his administrative responsibilities as general secretary of Yemen Cancer Society and founder of Aden cancer registry. He is serving as an editorial member of several journals like Yemen Oncology newsletter, Journal of pathobiology and toxicology. He has authored or co-authored many articles in a great variety of journals and has delivered lectures at many conferences and institutions in Yemen and internationally and referee for national and international journals. He is member of ESMO, ASCO, INCTR and Panarab Oncology.

 Biography
Research Interest :

Leukemia - lymphoma Gastrointestinal cancers

 Research Interest
 Network
 Acceptance Letter
Terry Lichtor

Terry Lichtor
Associate Professor
Department of Neurological Surgery
Rush University
USA
Read Interview session with Terry Lichtor

Biography :

Prof.Terry Lichtor has received his PhD in University of Chicago during the period of 1980.Currently,he is working as Associate Professor in Rush University,USA.He is serving as an editorial member of several reputed journals like American Journal of Medical and Biological Research and World Journal of Immunology. He has authored 63 research articles and 2 books. He is a member of American Medical Association. He has honored as America’s Top Surgeon.

 Biography
Research Interest :

Gene Therapy Strategies in the Treatment of Brain Tumors
Development of Brain Tumor Vaccines
Development of MRI Technology for Measurement of Intracranial Pressure Molecular Strategies in the Treatment of Alzheimer’s Disease

 Research Interest
 Network
Mirko Omejc

Mirko Omejc
Professor
Department of Abdominal Surgery
University of Ljubljana
Slovenia

Biography :

Dr.Mirko Omejc has received his PhD in University of Ljubljana during the period of 1996. Currently, he is working as Head of Department for Abdominal Surgery in University of Ljubljana, Slovenia. He has successfully completed his Administrative responsibilities as Professor of Surgery, Medical Faculty, University of Ljubljana.

 Biography
Research Interest :
 Research Interest
 Network
Manuela Stoicescu

Manuela Stoicescu
Department of Medical Disciplines
University of Oradea
Romania
 

Biography :
 Biography
Research Interest :

Internal Medicine, Cardiology, High blood pressure.

 Research Interest
 Network
 Acceptance Letter
Remigius U Agu

Remigius U Agu
Associate Professor
Pharmaceutics and Biopharmaceutics
Dalhousie University
Canada
 

Biography :

Remigius U. Agu was a practicing pharmacist before joining the academia. He has a Masters degree in Pharmacology (University of Nigeria) and Biopharmaceutics (University of Leuven, Belgium), respectively. He also has a PhD in Pharmaceutics and Biopharmaceutics from the University of Leuven, Belgium. As a scientist, Dr. Agu worked in Africa, Europe and USA before joining Dalhousie University in 2004. Currently, he is an Associate Professor of Pharmaceutics and Biopharmaceutics at the College of Pharmacy. Dr. Agu is also cross-appointed to the Department of Surgery, Dalhousie University, Halifax, Nova Scotia. He is involved in many basic science and clinical research in the areas of nasal/pulmonary drug delivery and pain management. Dr. Agu’s core research involves the development of novel respiratory drug delivery systems and testing methods. Dr. Agu is currently an editorial board member of two international journals and frequently reviews articles for more than twenty-top ranking pharmaceutical journals

 Biography
Research Interest :

He is involved in many basic science and clinical research in the areas of nasal/pulmonary drug delivery and pain management. Dr. Agu’s core research involves the development of novel respiratory drug delivery systems and testing methods.

 Research Interest
 Network
Zhe-Sheng Chen

Zhe-Sheng Chen
Professor
Department of Pharmaceutical Sciences
St. John′s University
USA
 

Biography :

Dr. Zhe-Sheng (Jason) Chen, M.D., PhD, is currently a Professor and a Director of Cancer Pharmacology Laboratory at College of Pharmacy and Health Sciences, St. John’s University. He joined St. John’s University in 2004 as an assistant professor. Since 2008, he established several research projects to study ABC transporters and multidrug resistance (MDR) as well as reversal of MDR in both in vitro and in vivo tumor models. During past 8 years, his laboratory has been well funded by NIH and Companies. He published more than 100 peer-reviewed research articles and 2 book chapters. He carried out his postdoctoral training at Fox Chase Cancer Center (Philadelphia, USA, 2000-2004) and Kagoshima University Faculty of Medicine (Japan, 1998-2000). He received his Ph.D. degree from Kagoshima University Faculty of Medicine (Japan, 1994-1998), Master degree from Sun Yat-Sen University School of Public Health (China, 1985-1988) and M.D. from Guangdong Medical and Pharmaceutical College (China, 1980-1985).

 Biography
Research Interest :

Physiology, Pharmacology and Pathology of ATP-binding cassette (ABC) transporters; Cellular and Molecular Mechanisms of multidrug resistance. Chen laboratory is interested in the molecular and cellular pharmacology of anticancer drugs, such as drug resistance mechanisms and reversal of resistance study and new drug development. A promise of our research program is that progress in the chemotherapy of cancer will depend on rational combination of agents that reduce the function of plasma membrane transporters such as P-gp, ABCG2 and MRPs, and to enhance the actions of cytotoxic drugs. In collaboration with many researchers in USA, China, Japan, Canada, Australia and Egypt, studies in Chen’s laboratory focus on screening and identifying new inhibitors of ABC transporters by in vitro membrane vesicles transport assay system and cell based assay systems. Another research direction is to study the role of ABC transporters family on the detoxification of chemicals (including carcinogens and mutagens) using knock out mouse models.

 Research Interest
 Network
Kathleen A Packard

Kathleen A Packard
Associate Professor
Department of Pharmacy Practice
Creighton University
USA
 

Biography :

Dr. Packard received her Doctor of Pharmacy and Masters in Pharmaceutical Sciences degrees from Creighton University in 2001. She completed a post-doctoral fellowship in cardiovascular research at the Cardiac Center of Creighton University in Omaha, Nebraska. Dr. Packard joined the Nebraska Heart Institute in 2003 as Director of Research. In 2007, she returned to Creighton University as faculty in the department of Pharmacy Practice. Dr. Packard provides inpatient clinical pharmacy services to patients in the cardiac unit at the Bryan Health Medical Center East and outpatient services at the cardiac rehabilitation clinic at Bryan Health LifePointe. She currently teaches cardiovascular pharmacotherapy to pharmacy students and conducts research in many areas of cardiovascular therapeutics, primary prevention and related pedagogy.

 Biography
Research Interest :

She currently teaches cardiovascular pharmacotherapy to pharmacy students and conducts research in many areas of cardiovascular therapeutics, primary prevention and related pedagogy.

 Research Interest
 Network
Zara Risoldi Cochrane

Zara Risoldi Cochrane
Assistant Professor
Department of Pharmacy Practice
Creighton University
USA
 

Biography :

Dr. Risoldi Cochrane earned her Doctorate of Pharmacy from Shenandoah University’s Bernard J. Dunn School of Pharmacy in 2008. She completed a specialty residency in drug information at the Creighton University Center for Drug Information and Evidence-Based Practice in Omaha, NE. Since then, Dr. Risoldi Cochrane has chosen to remain at Creighton University School of Pharmacy and Health Professions as a Drug Information Specialist and Assistant Professor of Pharmacy Practice. In addition to teaching didactic and experiential pharmacycourses, Dr. Risoldi Cochrane serves as formulary liaison to Creighton University Medical Center and provides full Pharmacy & Therapeutics Committee support. Additionally, she precepts the longitudinal drug information experience for the postgraduate pharmacy residents at Creighton University Medical Center, Creighton University Clinic Pharmacy, and Bergan Mercy Medical Center. An advocate for global health, Dr. Risoldi Cochrane has participated in several international medical missions and has been nationallyrecognized for her volunteer service.

 Biography
Research Interest :

Dr. Risoldi Cochrane’s areas of interest have included drug literature evaluation, evidence-based medicine, health literacy and health communication. She has published research in several peer-reviewed journals, including the Journal of Health Communication, Journal of Evidence-Based Complementary and Alternative Medicine, Journal of Dietary Supplements, and Translational Andrology and Urology

 Research Interest
 Network
 Acceptance Letter
Leanne L Lai

Leanne L Lai
Professor
Department of Sociobehavioral Administrative Pharmacy
Nova Southeastern University
USA
 

Biography :

Professor Leanne L Lai has received her PhD in University of Maryland during the period of 1996. Currently, she is working as Professor in Nova Southeastern University, USA. She has successfully completed her Administrative responsibilities as Director of International Pharmacy Program- Nova Southeastern University, College of Pharmacy (2002- 2011). She is serving as an editorial member of several reputed journals like Journal of Managed Pharmaceutical Care. She has authored 108 research articles and published 24 scientific articles. She is a member of Pharmaceutical and Therapeutic Committee – State of Florida (2001 - 2007) and Drug Utilization Review Board – State of Florida (1998-2010).

 Biography
Research Interest :

• Pharmacoeocnomics and Outcome Research
• Pharmacoepidemiology and Secondary Data Analysis
• International Education

 Research Interest
 Network
 Acceptance Letter
Michael A Gillette

Michael A Gillette
Assistant Professor
Department of Pharmacy Practice
Nova Southeastern University
USA
 

Biography :

Dr. Michael A. Gillette is a pharmacist researcher in the area of cardiovascular diseases. He graduated from Nova Southeastern University and completed his post-graduate training in cardiology with the Department of Veterans Affairs in affiliation with the University of Florida. He has been appointed as an assistant professor at his alumni, Nova Southeastern University College of Pharmacy, and continues to contribute to primary research in the area of cardiovascular diseases. He has been a reviewer for high impact pharmacology journals such as Pharmacotherapy, Annals of Pharmacotherapy, Hospital Pharmacy and Journal of Health System Pharmacy Residents.

 Biography
Research Interest :

Cardiovascular Diseases
Outcomes Research
Meta-Analysis
Geriatric Medicine

 Research Interest
 Network
Hamid Omidian

Hamid Omidian
Associate Professor
Department of Pharmaceutical Sciences
Nova Southeastern University
USA

Biography :

Dr. Omidian (Ph.D. in chemical engineering, polymer science), served in both academia and industry for about 23 years. He joined Purdue University in 2001, and pursued his research fellowship in the department of industrial and physical pharmacy. He joined industry in 2002 and served at different professional positions at Kos Pharmaceuticals and Abbott Laboratories. Dr. Omidian has over 120 peer-reviewed publications and presentations, author and co-author of dozens book chapters and books, and holding 3 US patents and over 10 US and world patent applications. He is currently serving as an associate professor at Nova Southeastern University’s college of pharmacy, and as an associate editor and editorial board member of several journals. He is also recipient of many research and teaching awards, including Golden Apple in Teaching. His major research areas are hydrogels for pharmaceutical and biomedical applications, gastric retention drug delivery and abuse-deterrent pharmaceutical dosage forms.

 Biography
Research Interest :

His major research areas are hydrogels for pharmaceutical and biomedical applications, gastric retention drug delivery and abuse-deterrent pharmaceutical dosage forms.

 Research Interest
 Network
 Acceptance Letter
Karen Falck Marlowe

Karen Falck Marlowe
Associate Department Head
Department of Pharmacy Practice
Auburn University
USA
 

Biography :

Karen F. Marlowe, Pharm D, BCPS,CPE–After graduating from Auburn University, Karen completed her pharmacy practice residency at Children’s Healthcare of Atlanta.In 2000, sheaccepted an appointment with Auburn University with a practice affiliated with the University of South Alabama Medical School, Department of Internal Medicine. Sheprovidespharmacotherapy consults forinpatient internal medicine patients, and also maintains a consult service for pain management and end of life care. This unique consult service is based on providing advocacy to patients and care providers to increase access to appropriate pain management and symptom management.Her research interests revolve around the attitudes/perceptions of practitioners regarding chronic pain patients and how their beliefsimpact the care these patients receive. She is also pursuing information related to opioids and how they impact the care of chronic pain patients. For the last three years, shehas served as the Assistant Dean of the Mobile Satellite Campus for the Harrison School of Pharmacy as well as the Associate Department Head for the Department of Pharmacy Practice.

 Biography
Research Interest :

Her research interests revolve around the attitudes/perceptions of practitioners regarding chronic pain patients and how their beliefsimpact the care these patients receive. She is also pursuing information related to opioids and how they impact the care of chronic pain patients.

 Research Interest
 Network
Harsh Chauhan

Harsh Chauhan
Assistant Professor
Department of Pharmacy Sciences
Creighton University
USA
 

Biography :

Dr. Harsh Chauhan is an Assistant Professor at Creighton University,Omaha, NE. Dr. Chauhan received his Ph.D. in Pharmaceutics from MCPHS,Boston, MA. His research emphasizes on amorphous systems and solid lipidnanoparticles. He worked as visiting scientist at Vertex pharmaceuticalsand his professional affiliations include AAPS, ACS and AACP.

 Biography
Research Interest :

Research and educational interest includes Pharmaceutical drug delivery systems, drug toxicity, drug resistance, role of meditation in healthy lifestyle, behavioral and psychological issues associated with medication.

 Research Interest
 Network
Rais A Ansari

Rais A Ansari
Assistant Professor
Department of Pharmaceutical Sciences
Nova Southeastern University
USA
 

Biography :

Professor Rais A Ansari has received his PhD in Kanpur University, India during the period of 1980-1985. Currently, he is working as Assistant Professor in Nova Southeastern University, USA. He has successfully completed his Administrative responsibilities as Adjunct Professor, Kent State University,USA. He is serving as an editorial member of several reputed journals like American Journal of Biochemistry and Drug Intoxication and Detoxification: Novel Approaches. He has authored 60 research articles and one book. He is a full member for Society of Toxicology since 1993.

 Biography
Research Interest :

1. Regulation of human angiotensinogen gene by xenobiotics and its role in hepatotoxicity and hypertension.
2. Mechanism of Hepatosteatosis after Xenobiotics: Role of Transport Process. 3. Role of transport protein(s) variants in drug toxicity and safety.
4. Establishment of viral/eukaryotic/mammalian expression systems for expression and purification of recombinant proteins for drug discovery.

 Research Interest
 Network
Liqin Zhao

Liqin Zhao
Associate Professor
Pharmacology & Pharmaceutical Sciences
University of Southern California
USA
 

Biography :

Dr. Zhao received her Ph.D. in Pharmaceutical Sciences from Shenyang Pharmaceutical University in China in 1999. She continued her postdoctoral research in neuroscience at the Beijing Institute of Pharmacology and Toxicology, where she was awarded two prestigious grants on neurodegenerative disease drug discovery from the China Postdoctoral Research Foundation and the National Natural Science Foundation of China. Dr. Zhao joined the University of Southern California (USC) in 2002 and is now a Research Associate Professor of Pharmacology and Pharmaceutical Sciences in the School of Pharmacy. Dr. Zhao has served as a PI/Co-PI on multiple funded projects including two investigator-initiated grants from the Alzheimer’s Association, one clinical trial (R01) and two program project (P01) grants from the National Institute on Aging. She has authored nearly 50 peer-reviewed research articles, 50 conference presentations, 5 patents, and served as an editor/reviewer for over 30 medical research journals.

 Biography
Research Interest :

Two-level interdisciplinary research on neuroendocrine aging and neurodegeneration (with an emphasis on Alzheimer’s disease; AD) aims:
1. At the basic level, to understand the neurobiological effects of sex hormones and the molecular basis underlying sex differences in the risk of developing AD. Some particular areas of interest include menopause/perimenopause, insulin/IGF signaling, cellular bioenergetics, amyloid metabolism, apolipoproteins, and gene expression and regulation.
2. At the translational level, to advance basic scientific findings into therapeutic development for prevention and early intervention of age-related conditions and neurodegeneration.
Some particular areas of focus include non-hormonal alternative therapies, estrogen receptor betaselective modulators, phytochemicals, and lifestyles in modulation of aging.

 Research Interest
 Network
 Acceptance Letter
Robert A Lodder

Robert A Lodder
Professor
Department of Pharmaceutical Sciences
University of Kentucky
USA
 

Biography :

Dr. Robert Lodder is a Professor of Pharmaceutical Sciences at the College of Pharmacy, University of Kentucky Medical Center, where he joined the faculty in 1988. He is also President of Spherix Incorporated. Dr. Lodder holds joint appointments as a professor in the Department of Electrical and Computer Engineering, and in the Department of Chemistry at Kentucky (Division of Analytical Chemistry). Dr. Lodder has over a dozen awarded patents, ten additional pending patent applications, and has founded three other venture-funded companies based on products of his research. Dr. Lodder was appointed as an SGE by the U.S. Food and Drug Administration. Dr. Lodder publications and projects have spanned pharmaceutical, preclinical and clinical uses. patented 5 new drugs that have been licensed to the pharmaceutical industry. As an analytical chemist, he has also converted a score of techniques to PAT use. Using data developed from these projects, Dr. Lodder has conducted mathematical studies aimed at solving the "false-sample" problem in thought-like operations on parallel processors and clouds. The cloud concepts have been extended to analytical instrumentation itself in the form of systems for magnetohydrodynamic acoustic-resonance near-infrared spectrometry (MAReNIR). Dr. Lodder is author of 110 publications and over 300 presentations. Dr. Lodder was first-prize winner in the 1990 international IBM Supercomputing Competition, as well as a winner of a National Science Foundation Young Investigator Award, the American Society of Agricultural Engineers Paper Award, a Buchi NIR Award, the Tomas Hirschfeld Award in Near-IR Spectroscopy (PittCon), and a Research and Development 100 Award.

 Biography
Research Interest :

As an analytical chemist, he has also converted a score of techniques to PAT use. Using data developed from these projects, Dr. Lodder has conducted mathematical studies aimed at solving the "false-sample" problem in thought-like operations on parallel processors and clouds. The cloud concepts have been extended to analytical instrumentation itself in the form of systems for magnetohydrodynamic acoustic-resonance near-infrared spectrometry (MAReNIR).

 Research Interest
 Network
 Acceptance Letter
Bodhisattwa Chaudhuri

Bodhisattwa Chaudhuri
Assistant Professor
Department of Pharmaceutical Sciences
University of Connecticut
USA
 

Biography :

Dr. Chaudhuri holds Assistant Professor position in the Department of Pharmaceutical Sciences at the University of Connecticut. He got his BS and MS in Chemical Engineering from Jadavpur University, Calcutta and Indian Institute of Science, Bangalore respectively. Thereafter, he got his PhD in Mechanical Engineering from New Jersey Insititute of Technology and worked in the telecommunication industry for 3 years. He joined University of Connecticut as as Assistant Professor in Pharmaceutical Technology after 4 years of postdoctoral research in Department of Chemical Engineering and NSF-Engineering Research Center in Rutgers University. He has given 6 invited talks and the author of more than 50 book chapters, journal publications and conference proceedings. He currently serves in the Editorial board of several journals and in the advisory committees of multinational companies and international conferences. Dr. Chaudhuris research on Pharmaceutical Technology is supported by FDA, NIH, PhRMA Foundation, Pfizer, Boehringer Ingelhiem and CPPR.

 Biography
Research Interest :

My general research area is experimentally validated high performance scientific computing, particularly in the areas of multi-scale modeling of complex fluid, materials, biological systems and nano-pharmaceuticals.

 Research Interest
 Network
Jay Babu Ramapuram

Jay Babu Ramapuram
Associate Professor
Department of Pharmaceutical Sciences
Auburn University
USA
 

Biography :

Jay Babu Ramapuram is Associate Professor of Pharmaceutics at Harrison School of Pharmacy, Auburn University. He received his Ph.D. Degree (Pharmaceutics) in 1998 from Institute of Technology, Banaras Hindu Unviersity, India. He teaches various pharmaceutics courses to Pharm D students and at the graduate level at Auburn University. His research interests include: topical and transdermal delivery, nanoparticle formulation and characterization, excipient characterization, formulation of solid dose products, solubility improvement of drugs. He has published over 50 peer-reviewed abstracts and 50 research articles.

 Biography
Research Interest :

His research interests include: topical and transdermal delivery, nanoparticle formulation and characterization, excipient characterization, formulation of solid dose products, solubility improvement of drugs.

 Research Interest
 Network
 Acceptance Letter
Frank M Etzler

Frank M Etzler
Associate Professor
Department of Pharmaceutical Sciences
Lake Erie College of Osteopathic Medicine
USA
 

Biography :

Dr. Etzler earned a Ph.D. in physical chemistry from the University of Miami. He is currently an Associate Professor of Pharmaceutics in the School of Pharmacy at the Lake Erie College of Osteopathic Medicine (LECOM). Prior to coming to LECOM in 2011, he was the leader of the Material Science Laboratory at Boehringer-Ingelheim Pharmaceuticals for nearly 20 years. This laboratory was responsible for the physical characterization of powders. Dr. Etzler was involved with the development of Spriva. Prior to this, Dr. Etzler was a faculty member in pharmaceutics at the University of Kentucky and a faculty member in surface and colloid science at the former Institute of Paper Chemistry.

 Biography
Research Interest :

Pharmaceutics - Pulmonary Formulation, Solids Formulation, Preformulation. Adhesion Science
Particle Size Analysis
Mechanical Properties of Solids
Powder Compaction
Powder Flow

 Research Interest
 Network
Ronald R Burnette

Ronald R Burnette
Professor
Department of Pharmaceutical Sciences
University of Wisconsin-Madison
USA
 

Biography :

Ron received his B.S. degree (1971) in electrical engineering from the University of California-Irvine, M.S. degree (1973) in electrical engineering from Stanford University, and Pharm.D. (1979) and Ph.D. (1982) degrees in pharmaceutical chemistry from the University of California-San Francisco. He joined the Wisconsin faculty in 1982.

 Biography
Research Interest :

      At the whole organism level (animal and human), our research group is interested in developing computer algorithms, using the principles obtained from pharmacokinetics, pharmacodynamics and pharmacogenomics, in order to optimize drug delivery and to understand drug interactions.
       At the molecular level, the basic premise underlying our research is that one can combine experimental data, such as that obtained from spectroscopic techniques and X-ray crystallography, in a synergistic manner with computational chemistry to determine molecular structure and to understand intermolecular and intramolecular interactions. This, in turn, provides the basis for beginning to understand drug delivery systems at a more fundamental level. More precisely these investigations provide a mechanism by which one can start to predict how specific molecular changes will alter a drug delivery system at both the structural and energetic level.

 Research Interest
 Network
Taimour Langaee

Taimour Langaee
Associate Professor
Department of Pharmacotherapy and Translational Research
University of Florida
USA
 

Biography :

Taimour Y. Langaee, MSPH, Ph.D., is Research Associate Professor in the Department of Pharmacotherapy and Translational Research at the University of Florida (UF) College of Pharmacy and Director of the UF Center for Pharmacogenomics Genotyping Core Laboratory. Before joining the UF faculty in 2002, he completed three years of post-doctoral fellowship in Immunology and Molecular Biology, and Microbiology and Molecular Genetics working on developing HIV vaccine at the College of Medicine University of Montreal and High Density DNA chips for Pseudomonas aeruginosa at the College of Medicine University of Florida.

 Biography
Research Interest :

Dr. Langaee's research interests are focused on pharmacogenomics (genetic-based variability in drug response) in cardiovascular disease; pharmacogenomics of anticoagulants (Warfarin); Pharmacogenetics of Dichloroacetate(DCA); Clinical, Geneticsand Microbial Interactions in Inflammatory Bowel Disease (IBD); Microbial resistance to antibiotics.

 Research Interest
 Network
Deepak Gupta

Deepak Gupta
Assistant Professor
Department of Pharmaceutical Sciences
Lake Erie College of Osteopathic Medicine
USA
 

Biography :

Dr. Gupta obtained his B.Pharmacy from Guru Jambheshwar University, India and his M.S. (Pharmaceutical Sciences) fromPoona College of Pharmacy, India.His project involved synthesis and evaluation of prodrugs of anti-inflammatory and anti-cancer agents. Later, he underwent training at Central Drug Research Institute (CDRI), Lucknow, India in drug design and molecular modeling. His Ph.D. dissertation mainly focused on the design, synthesis and biological evaluation of mechanism based inhibitors targeting malaria. Dr. Gupta later joined University of Michigan (UM) as postdoctoral research fellow under Dr. Gordon Amidon at the Center for Molecular Drug Targeting.At UM, he was involved in the design, synthesis, in-vitro, in-situ and in-vivo evaluation of Influenza drugs and also MRI active contrast agents for diagnosis of solid tumors. He joined LECOM-School of Pharmacy in July 2009 as assistant professor of Pharmaceutical Sciences. He is currently the Director of Center of Drug Delivery and Targeting (CDDT) at LECOM.

 Biography
Research Interest :

• Drug Design And Development
• Drug Delivery (Prodrugs)
• Mucosal Transport and Transporters
• Drug Metabolism and Activation Pathways

 Research Interest
 Network
Grant H Skrepnek

Grant H Skrepnek
Associate Professor
Department of Pharmacy Practice & Science
University of Arizona
USA
 

Biography :

Grant H. Skrepnek, Ph.D., M.Sc., R.Ph., is an Associate Professor with Tenure at The University of Arizona College of Pharmacy. He additionally serves as a Full Investigator within The University of Arizona Cancer Center (UACC), an Affiliate of the Arizona Water Institute, and an Investigator within the Center for Health Outcomes and PharmacoEconomic Research (HOPE), the Arizona Emergency Medicine Research Center (AEMRC), and the Venom Immunochemistry, Pharmacology, and Emergency Response (VIPER) Institute. Dr. Skrepnek received his B.S., M.Sc., and Ph.D. in Pharmacy at The University of Texas at Austin, where he conducted research on the industrial economics of the pharmaceutical industry and completed his minor area studies in both finance and management.

 Biography
Research Interest :

As faculty at The University of Arizona, Dr. Skrepnek concentrates on health economics, policy, and outcomes research involving large-scale database investigations, decision analyses, clinical trials, and survey research. From a clinical stance, Dr. Skrepnek has focused on studying cost, quality, and access to care across various healthcare settings concerning oncology, cardio-pulmonary disease, rare conditions, and comorbidities. Furthermore, he is engaged in advancing the methodological approaches used within assessments of health technology, including the development of novel statistical procedures to evaluate health and economic data. His interests extend to policy issues concerning Medicare and Medicaid, industrial organization economics in the pharmaceutical industry, and financial econometrics. Dr. Skrepnek also studies practice-related aspects of healthcare which include reimbursement, academia, safety, patient compliance and adherence, treatment guideline implementation, disease management, and the use of technology by clinicians. He has received funding from numerous organizations and was a co-investigator within The University of Arizona\'s Center for Education and Research on Therapeutics (CERT) funded by the Agency for Healthcare Research and Quality (AHRQ).

 Research Interest
 Network
James G Mitroka

James G Mitroka
Associate Professor
Palm Beach Atlantic University
Gregory School of Pharmacy
USA
 

Biography :

Dr. Mitroka earned a B.S. in Chemistry from Michigan State University, and a Ph.D. in Pharmacology and Toxicology from Rutgers University. Prior to joining PBA, he worked for Bristol-Myers Squibb as a research group leader and conducted studies to determine the metabolic fate of experimental drugs. Jim’s experience includes studies involving stable and radioactive isotopes both in vivo and in vitro. Jim left in 2008 BMS to begin teaching at the Palm Beach Atlantic Gregory School of Pharmacy. He teaches medicinal chemistry, pharmacology, and pharmacogenomics. Jim’s research interest includes the use of biomarkers to evaluate the impact of behavioral interventions and natural products on health and disease.

 Biography
Research Interest :

Jim’s research interest includes the use of biomarkers to evaluate the impact of behavioral interventions and natural products on health and disease.

 Research Interest
 Network
Mutasem Rawas-Qalaji

Mutasem Rawas-Qalaji
Assistant Professor
Department of Pharmaceutical Sciences
Nova Southeastern University
USA
 

Biography :

Dr. Rawas-Qalaji earned his Ph.D. in Pharmaceutics (2006) from the University of Manitoba, Canada. He received several international, national, provincial, and institutional awards. He was awarded Strategic Training in Allergy Research Award from the American Academy of Allergy, Asthma & Immunology’s, The Canadian Foundation for Pharmacy National Award, Manitoba Health Research Council Award, Manitoba Institute of Child Health Award, Manitoba Pharmaceutical Association Award, and University of Manitoba Fellowship. He joined QLT Inc. (2007) in Vancouver, Canada, as a postdoc in Preclinical Formulation and was awarded Natural Sciences and Engineering Research Council Fellowship. Also, he worked as a formulation scientist for ENWAVE Corp. (2008) in Vancouver, Canada. He joined Nova Southeastern University (2008-present) in Fort Lauderdale, Florida as an Assistant Professor at the College of Pharmacy. He has more than 39 peer-reviewed publications, 37 conference and podium presentations, and 13 patent applications.

 Biography
Research Interest :

- Pharmaceutical Dosage Form Design and Development
- Nanoparticles and nanocrystals fabrication and charcterization
- In Vitro / Ex vivo / In vivo Studies
- Analytical Analysis
- Statistical Analysis

 Research Interest
 Network
Micheal S Guirguis

Micheal S Guirguis
Adjunct Professor
Department of Pharmacy and Pharmaceutical Sciences
University of Alberta
Canada
 

Biography :

Dr. Micheal Guirguis provides scientific and administrative support to the Alberta Health and Wellness Expert Committee on Drug Evaluation and Therapeutics, specifically in the areas of interchangeability and bioequivalence. Previously, Dr. Guirguis worked at Abbott Laboratories and Covance Labs, as a clinical pharmacokineticist supporting the design and analysis of pharmacokinetic studies. In addition Dr. Guirguis is an Adjunct Professor of Pharmacy and Pharmaceutical Sciences at the University of Alberta supporting education and research in Pharmacometrics, and Pharmacokinetics. As well as a Recognized Instruction and Dissertation Advisor at the University of Liverpool/Laureate online based Masters in Clinical Research.

 Biography
Research Interest :

Pharmacometrics and Pharmacokinetics

 Research Interest
 Network
Sudip K Das

Sudip K Das
Associate Professor
Department of Pharmaceutics
Butler University
USA

Biography :

Dr. Sudip K. Das is the Director of the Graduate Program and Research in Pharmaceutical Sciences and Associate Professor of Pharmaceutics at the College of Pharmacy & Health Sciences, Butler University, Indianapolis, IN, where he also served as the chair of the Department of Pharmaceutical Sciences from 2004-09. Dr. Das has over twenty years of teaching and research experience in the professional pharmacy and graduate programs in the USA and Canada. He has supervised a number of postdoctoral, graduate and undergraduate research students, and was the key faculty responsible for the revitalization of the graduate program and research infrastructure in pharmaceutical sciences at Butler University. His current research involves targeted delivery of siRNA and nano-composites for the treatment of cancer and neurodegenerative diseases. Dr. Das has over 150 research publications, review articles, US patents, proceedings, conference presentations, and book chapters, is a recipient of multiple awards/honors, and has secured extramural research funding from NIH,PDA,etc., and the pharmaceutical industry. Dr. Das is also an active member of AAPS (since 1991) and CRS (Controlled Release Society, since 1987). He has served on many committees of the PDD/PPB and BIOTEC sections of AAPS. Since 2004, he has served on several study sections on drug delivery and bioengineeringofthe NIH - Center for Scientific Review, and continues to serve on the editorial boards of many reputed journals.

 Biography
Research Interest :

Targeted drug delivery for anticancer drugs and siRNA, nanomedicine, translational research

 Research Interest
 Network
 Acceptance Letter
John M Seubert

John M Seubert
Adjunct Associate Professor
Department of Pharmacology
University of Alberta
USA
 

Biography :

Dr. Seubert obtained his BSc in biology and MSc in aquatic toxicology with from Simon Fraser University. He received his Doctorate in Pharmacology andToxicology from the Faculty of Medicine at the University of Western Ontario. He went on to complete a fellowship in Cardiovascular Pharmacology at the National Institute of Environmental Health Science in Research Triangle Park, NC, under the supervision of Dr. Darryl Zeldin. Dr. Seubert established his own independent research laboratory in the area of cytochrome P450-dervied metabolites of arachidonic acid health and disease,in the Faculty of Pharmacy and Pharmaceutical Sciences at the University of Alberta, where he has an adjunct appointment in the Department of Pharmacology. He received a New investigator Award from the Heart and Stroke Foundation of Canada in 2007 and is an Alberta Innovates Health Scholar. He is as an active member of the Cardiovascular Research Centre and the Mazankowski Heart Institute and the Toxicology Research Group at the University of Alberta.

 Biography
Research Interest :

Research in our lab is focused on investigating the cellular role of cytochrome P450-dervied metabolites of arachidonic acid (epoxyeicosatrienoic acids – EETs) in maintaining cellular and tissue homeostasis and reducing injury.

 Research Interest
 Network
Esther Woon

Esther Woon
Assistant Professor
Department of Pharmacy
National University of Singapore
Singapore
 

Biography :

Dr Esther Woon received her Ph.D. in Medicinal Chemistry from the University of Bath, Department of Pharmacy in 2004. She then received an AICR postdoctoral fellowship to study the mechanism and inhibition of protein-protein interaction at the UCL School of Pharmacy. In 2008, she was awarded a European Union-funded postdoctoral fellowship to work on epigenetic probe discovery at the University of Oxford, Department of Chemistry, where she contributed to the first report of several highly selective and potent small molecule probes for the histone and nucleic acid demethylases. This work enabled subsequent functional and mechanistic studies on these enzymes. She is currently an Assistant Professor at the Department of Pharmacy, National University of Singapore. She continues to work in the field of epigenetics, and is the leading group in developing dynamic boron chemistry-based methods for rapid probe/ drug discovery.

 Biography
Research Interest :

1. Development of selective and cell-active probes to study the epigenetic basis for obesity and other metabolic diseases.
2. Applying a combination of crystallographic and other biophysical techniques to understand the mechanism for substrate specificity for the JmjC histone demethylases.
3. Development of Dynamic Combinatorial Chemistry (DCC)-based techniques suitable for the rapid discovery of drugs.

 Research Interest
 Network
Mohammad Nasir Uddin

Mohammad Nasir Uddin
Assistant Professor of Pharmacy
Levine College of Health Sciences
Wingate University
USA
 

Biography :

Mohammad Nasir Uddin is an Assistant Professor in School of Pharmacy at Lake Erie College of Osteopathic Medicine, LECOM. He completed his Bachelor degree in Chemistry from Jahangirnagar University, Dhaka Bangladesh. He received his M. Sc. in Chemistry from Emory University, Atlanta in 2006. He received his Ph.D in Pharmaceutics from Mercer University, Atlanta in 2011. He was also a faculty member at Science department, Georgia Perimeter College, Dunwoody. Georgia. He worked on nano-particle based vaccine development for Human Papillomavirus (HPV) as scientist at CDC in 2010 and 2011. His research has lead to 14 peer reviewed papers and numerous scientific presentations. He is also member of several Professional Organization including Association of American Pharmacy Scientists (AAPS) American Association of Colleges of Pharmacy (AACP), Control Release Society (CRS) American Society of Microbiology (ASM), and American Chemical Society (ACS)

 Biography
Research Interest :

My research interest involves the study of developing vaccines for most prevalent and challenging diseases using micro/nano particle platform based technology. The research mainly focused on development of particulate vaccine against Human Papillomavirus (HPV) for both prophylactic and therapeutic use for cervical cancer. My further research interests include oral formulation development using nano or micro particle for infectious diseases. I am also interested in adhesion and development of nanoparticles for drug delivery purpose.

 Research Interest
 Network
Robert A Freeman

Robert A Freeman
Professor
Department of Pharmacy Practice & Administration
University of Maryland
USA
 

Biography :

Dr. Robert Freeman is currently Professor of Pharmacy Administration (health services research) in the Department of Pharmacy Practice & Administration at the University of Maryland Eastern Shore School of Pharmacy. He has over 20 years’ experience in the global pharmaceutical industry having served as a leader of public policy and health economics functions for AstraZeneca and Sanofi among others. Prior to his current academic position he was Professor of Pharmaceutical Sciences and Director of Graduate Studies at the Rangel College of Pharmacy at Texas A&M Health Sciences Center. He is the author of over 75 research and professional publications in comparative effectiveness research, public policy, health economics & outcomes research and pharmaceutical industry finance economics. His current research focuses on policy initiative to incentivize pharmaceutical R&D. He earned his BS in Pharmacy and his MS and PhD degrees from the University of Mississippi.

 Biography
Research Interest :

His current research focuses on policy initiative to incentivize pharmaceutical R&D.

 Research Interest
 Network
 Acceptance Letter
Cesar M Compadre

Cesar M Compadre
Professor
Department of Pharmaceutical Sciences
University of Arkansas Medical Sciences
USA
 

Biography :

Dr. Compadre has extensive research experience, on the development of bioactive compounds based on naturally occurring compounds, and on the use of molecular modeling in drug design and structure-activity studies. He has published over papers and over 70patents related to the development of bioactive compounds, and one FDA approved antimicrobial technology. Dr. Compadre has a BSPharm degree, and obtained his Ph.D degree in medicinal chemistry and pharmacognosy, from the University of Illinois at Chicago. He conducted postdoctoral research on structure-activity relationships studies using molecular modeling at the University of Illinois working with Dr. John M. Pezzuto and at Pomona College working with Professor Corwin Hansch. Additionally, he had a sabbatical experience at NASA Ames Research Center in computer modeling. At the University of Arkansas for Medical Sciences he established and directs the molecular modeling facility. He has extensive research collaborations with many scientists locally, nationally and internationally.

 Biography
Research Interest :

Dr. Compadre has extensive research experience, on the development of bioactive compounds based on naturally occurring compounds, and on the use of molecular modeling in drug design and structure-activity studies

 Research Interest
 Network
Christopher W Ho

Christopher W Ho
Assistant Professor
Department of Pharmacy Practice
Long Island University
USA
 

Biography :

Dr. Christopher Ho is an assistant professor at the Arnold and Marie Schwartz College of Pharmacy and Health Sciences in Brooklyn, NY. He earned his Bachelor of Science degree in Biochemistry from Stony Brook University and his Doctor of Pharmacy degree from the Massachusetts College of Pharmacy and Health Sciences in Worcester, MA. He then moved on to complete a PGY1 pharmacy practice residency at the James J. Peters VA Medical Center in the Bronx, NY. He is board certified in ambulatory care and is currently practicing as a clinical pharmacy specialist in the ambulatory care areas of diabetes and primary care at the Brooklyn VA Medical Center, where he offers rotations for both pharmacy students and residents. At the college, he teaches courses in both the pharmacy and physician assistant programs in areas such as acute coronary syndromes, ischemic heart disease, colorectal cancer, and drugs of abuse. He is also currently the president-elect of the Royal Counties Society of Health-System Pharmacists and his research interests include the areas of diabetes and cardiology.

 Biography
Research Interest :

Diabetes and Cardiology.

 Research Interest
 Network
 Acceptance Letter
Katerina Venderova

Katerina Venderova
Assistant Professor
Department of Physiology and Pharmacology
University of the Pacific
USA
 

Biography :

Dr. Venderova is an Assistant Professor at the University of the Pacific, with expertise in neuropharmacology and neurogenetics. Her research is centered on pathogenesis of neurodegenerative processes in an effort to find effective disease-modifying treatments. She received several international awards and fellowships in recognition of her work, such as the Melvin Yahr Fellowship, the Junior Faculty Award, and the Parkinson Society Canada basic research postdoctoral fellowship. She authored four textbook chapters, presented her findings at a number of invited talks, and serves as a reviewer for several highly respected journals and grant agencies. Prior to joining University of the Pacific’s Thomas J. Long School of Pharmacy, she was a postdoctoral fellow at the University of Ottawa, Faculty of Medicine, and at the Toronto Western Research Institute in Canada. She received a doctorate in pharmacy, followed by a PhD in Toxicology from the Charles University in Prague, Czech Republic.

 Biography
Research Interest :

Dr. Venderova’s core expertise is in genetics and molecular pathways involved in neurodegeneration, most notably in Parkinson’s disease and Alzheimer’s disease. The goal of her work is finding better pharmacological treatments of neurodegenerative disorders.

 Research Interest
 Network
Amy Z Wang

Amy Z Wang
Assistant Professor
Department of Pharmacy Practice
Long Island University
USA
 

Biography :

Dr. Amy Wang is an Assistant Professor of Pharmacy Practice at the Long Island University and a Clincial Pharmacy Specialist in Cardiology at the New York Methodist Hospital. She graduated from the University of Kentucky in 2006 with degrees of Doctor of Pharmacy and Master of Business Administration. She worked as a staff pharmacist after graduation at the Cleveland Clinic, in Cleveland, Ohio. Her Post-Graduate Year One Pharmacy Practice residency was completed at the St. John Hospital in Detroit, Michigan. Her Post-Graduate Year Two Critical Care residency was completed at the New York Methodist Hospital in Brooklyn, New York. Dr. Amy Wang took an Assistant Professor position at the Long Island University in 2009, and was BCPS certified in 2010. At New York Methodist Hospital, she attends daily clinical rounds with the Cardiology Team and precepts Pharmacy Residents and Pharmacy Students. Her research interests include anticoagulation, cardiology, and critical care.

 Biography
Research Interest :

My research interests include comparing efficacy and safety of antiplatelets for acute coronary syndrome, comparing efficacy of magnesium and Class III antiarrhythmic therapy versus antiarrhythmics alone for atrial fibrillation, and efficacy of digoxin for pulmonary arterial hypertension.

 Research Interest
 Network
 Acceptance Letter
Brian W Dymock

Brian W Dymock
Associate Professor
Department of Pharmacy
National University of Singapore
Singapore
Read Interview session with Brian W Dymock

Biography :

Prof.Brian W Dymock has received his PhD in University of Glasglow, UK during the period of 1997. Currently, he is working as Associate Professor in University of Singapore. He has successfully completed his Administrative responsibilities as Department Manager, Discovery Chemistry, Evotec, UK, Visiting Associate Professor, NUS Department of Pharmacy, Singapore. He has authored 62 research articles. He is a full member of the Royal Society of Chemistry (MRSC), UK and member of the American Chemical Society, USA .

 Biography
Research Interest :

• Fragment screening using Surface Plasmon Resonance (SPR) and Weak Affinity Chromatography (WAC)
• Hydrogen sulfide donor compounds as cardiovascular and anticancer agents
• Designed Multiple Ligands (e.g. HDAC-HSP90, HDAC-JAK combination drugs)
• Novel inhibitors of Histone Methyl Transferases (HMTs)
• Novel inhibitors of kinesin enzymes
• Targeting p53 modulators to cancer cells
• Selective Inhibitors of mTOR kinase

 Research Interest
 Network
Hong-yu Li

Hong-yu Li
Associate Professor
Department of Pharmacology and Toxicology
University of Arizona
USA

Biography :

Hong-yu Li is currently an associate professor of Medicinal Chemistry in College of Pharmacy, the University of Arizona. He received his Ph.D. degree from the University of Tokyo, and did his postdoctoral trainings at Columbia University (with Professor Koji Nakanishi) and Harvard University (with Professor Yoshito Kishi). He previously worked at Eli Lilly where he focused on oncology drug discovery.His current research interests are in chemical biology and drug discovery, especially for oncology related targets and phenotypes.In his lab at the University of Arizona, a highly potent (picomolar activity in an oncogene-driven cancer cell line), selective, and orally bioavailable small molecule drug inhibitor was discovered, and is currently ready for preclinical development and further IND filing.

 Biography
Research Interest :

Dr. Li’s research interest is drug discovery and development of kinase inhibitors for rare and/or neglected cancer diseases in a High-Throughput manner. To discover active hits, a novel type of kinase fragment library will be generated in a High-Throughput manner. This kinase fragment library will be designed to overcome most of issues concerning kinase fragment libraries. Compounds identified from the library as an active will be further optimized for better activity and toxicity profiles. The optimization will be done through the library synthesis approach, rather than the industry standard approach of solving SAR (structure-activity relationship) problems one molecule at a time. The one-by-one approach may work well in the beginning of the sequence of the drug discovery value chain, but you may run the risk of encountering the initial problems when trying to solve the next problem. One-cycle library iteration will produce a wide range of SAR information including toxicity for the next library design and production. Three to five cycle iterations of libraries will generate advanced compounds with properties to produce the desired in vivo efficacy with acceptable toxicity profile. The library design approach aided by the computer modeling and calculation will focus on solving any unforeseen SAR problems for each cycle.

 Research Interest
 Network
Georg F Weber

Georg F Weber
Associate Professor
College of Pharmacy
University of Cincinnati Academic Health Center
USA

Biography :

Georg F. Weber attended medical school in Wuerzburg, Germany. He worked at the Dana-Farber Cancer Institute, Harvard Medical School from 1990 through 1999 and is currently on the faculty at the University of Cincinnati. Georg F. Weber has published over 80 scientific reports, including many in the most respected professional journals, and various monographs, most recently a textbook on molecular oncology. He holds several patents. As a component of his mission to research cancer dissemination, Georg F. Weber is the founder and chief executive officer of MetaMolTheranostics, a company specialized in diagnosis and treatment of cancer metastasis.

 Biography
Research Interest :

Georg F. Weber has defined the genetic basis of metastasis formation as aberrant expression or splicing of a unique set of developmentally non-essential genes (stress response genes) that physiologically mediate the homing of immune system cells. Specifically, his laboratory has studied the cytokine osteopontin, which acts as a metastasis gene in multiple malignancies, including breast cancer. Based on the molecular mechanisms of osteopontin induction and function in cancer metastasis, he has established the following paradigms:
1. Osteopontin and variant CD44 interact, and this is essential for metastasis by several types of cancer.
2. Multiple osteopontin splice variants are present in malignant, but not in benign human breast tumor cells.
3. Metastasis genes support anchorage-independence in an autocrine fashion.
4. In cancer cells, distinct signal transduction pathways to growth and invasiveness are activated by oncogenes.
5. The expression (activation) of metastasis genes is triggered by cellular stress response programs and is regulated by multi-subunit transcription factor complexes. Georg F. Weber is the author of multiple monographs, most recently a textbook on molecular oncology.

 Research Interest
 Network
Zhe Sha

Zhe Sha
Department of Cell Biology
Harvard Medical School
USA
 

Biography :

Dr. ZheSha got his B.S. degree from the department of Biology at Fudan University. He then did his Ph.D. dissertation at Dr. Eric C. Chang’s laboratory at the Department of Molecular and Cellular Biology and the Lester & Sue Smith Breast Center at Baylor College of Medicine. His Ph.D. dissertation focused on identifying the mechanism by which Int6, a breast tumor suppressor gene, maintains protein homeostasis and genetic stability by promoting proper assembly and localization of the 26S proteasome. After graduation, Dr. Sha joined Professor Alfred L. Goldberg’s laboratory at the Department of Cell Biology at Harvard Medical School to conduct further research in the proteasome and cellular proteolysis area. His current research focuses on identifying cell killing mechanisms by proteasome inhibition, and cellular compensatory responses to promote survival.

 Biography
Research Interest :

Proteasome inhibition is toxic, especially to multiple myeloma cells, and the inhibitor, bortezomib/Velcade, has dramatically improved myeloma treatment. Diminished proteasome function also may contribute to neurodegenerative diseases. Consequently, understanding what consequences of proteasome inhibition causes death in various types of cells, and how different cells compensate for loss of protein degradation capacity in order to promote survival, will be very helpful to improve the Bortezomib therapy, and to pharmaceutically upregulate protein degradation capacity for the benefit of treating neurodegenerative diseases. To this end, I am pursuing two directions: (1) How do cells transcriptionally upregulate components of the ubiquitin-proteasome system and the autophagy-lysosomal system to increase protein degradation capacity; (2) How are proteasome composition (especially the abundance of substochiometric proteasome-binding proteins) and proteasome modifications are altered upon proteasome inhibition to modulate proteasome activity and amplify the inhibitory effect of Bortezomib.

 Research Interest
 Network
Robert Chunhua Zhao

Robert Chunhua Zhao
Director
Chinese Academy of Medical Sciences
China
 

Biography :

Robert Chunhua Zhao, M.D., Ph.D, is Cheung Kong Professor, Director of Center for Stem Cell and TE at CAMA& PUMC, the chief scientist of National 973 Basic Research Program of China and a Regional Editor of the Journal of Stem Cells and Development. His research is directed at studying the fundamental properties of stem cells and translating their unique biological properties into clinical application. In 2004 his group won the first official approval of “mesenchymal stem cell” from SFDA as to start clinical trials in China. Dr. Zhao has published 212 papers in international and domestic journals.

 Biography
Research Interest :

Studying the fundamental properties of stem cells and translating their unique biological properties into clinical application.

 Research Interest
 Network
Beili Zhu

Beili Zhu
University of Texas Health Center
USA
 

Biography :
 Biography
Research Interest :

My project will be creating new methods and developing microfluidic devices to separate different types of cells from native cardiac and skin tissue for applications in tissue engineering and cell-based tissue repair.

 Research Interest
 Network
John D Bullock

John D Bullock
Research Professor of Epidemiology
Wright State University
USA
 

Biography :

Dr. Bullock is a graduate of Dartmouth College and Harvard Medical School. He completed an internship in internal medicine at Washington University in St. Louis before serving in the U.S. Navy. After residency training in ophthalmology at Yale University, he completed fellowships at the University of California, San Francisco, and the Mayo Clinic. He received a Master of Science in Microbiology and Immunology from Wright State University and a Master of Public Health degree from the Harvard School of Public Health. He completed additional training from the Armed Forces Institute of Pathology, the CDC in Atlanta, the London School of Hygiene and Tropical Medicine, and the Pasteur Institute in Paris. He held a clinical faculty position at Stanford University before coming to Wright State, where he served as professor and chair of the department of ophthalmology, professor of physiology and biophysics and associate professor of microbiology and immunology, and was named the Brage Golding Distinguished Professor of Research. Dr. Bullock is the author or coauthor of more than 235 scientific publications. He discovered three new causes of blindness and elucidated the etiology and/or description of six different retinopathies. His research influenced the market withdrawal of two general anesthetics, a warning label for a pharmaceutical agent whose inappropriate use resulted in blindness, and a Consumer Products Safety Commission-mandated warning label. He is a Fellow of the American Academy of Ophthalmology, the American Academy of Pediatrics, the Infectious Diseases Society of America, the American College of Epidemiology and the Royal Society of Medicine. He is a member of Alpha Omega Alpha Honor Medical Society, Delta Omega Honorary Society in Public Health, the American Ophthalmological Society, the American Osler Society, the Cornea Society (Member with Thesis) and the American Society for Microbiology, among others. Dr. Bullock received a Heed Fellowship from the Heed Ophthalmic Foundation; the Wendell Hughes, Merrill J. Reeh, and the Marvin H. Quickert Awards from the American Society of Ophthalmic Plastic and Reconstructive Surgery; and the Senior Honor Award from the American Academy of Ophthalmology. In 2011 he received the Outstanding Scientific Project Award from the Vision Care Section of the American Public Health Association. He has numerous other awards (including teaching awards), copyrights, trademarks and inventions. He has given more than 500 lectures throughout the world, a number of which were distinguished named lectureships, and he served as president and secretary/treasurer of two international medical societies. He has served as a consultant to the National Institutes of Health, the Hospital Albert Schweitzer in Haiti, the U.S. Veteran’s Administration, the U.S. Air Force, the American Medical Association, and the Harvard-Hsiao Resource-Based Relative Value Study.

 Biography
Research Interest :

Ophthalmology
Anti-microbial agents

 Research Interest
 Network
 Acceptance Letter
Sarsvat Patel

Sarsvat Patel
Assistant Professor
Division of Pharmaceutical Sciences
Long Island University
USA

Biography :

Dr. Patel has received a Ph.D. in Pharmaceutics in 2010 from the National Institute of Pharmaceutical Education and Research (NIPER, India), an M. Pharm. in Pharmaceutical Technology (Formulations) from the NIPER, and a B.S in Pharmacy from the North Gujarat University, India. He joined the Division of Pharmaceutical Sciences in fall 2012 after working at the Department of Pharmaceutics, University of Minnesota, where he worked on many research projects related to preformulation, formulation development and pharmaceutical processing. He has published 16 research articles, filed 2 patent applications, worked on various industry-sponsored projects and received research grant. He is actively involved in research areas of pharmaceutics like – (i) Pre-formulation profiling (physico-chemical characterization, solubility, permeability), (ii) Pharmaceutical material characterization (amorphous, polymorphism, pseudo-polymorphism, salt, co-crystals), (iii) Manufacturing sciences (mechanical property, tableting, granulation, flow property) and (iv) Drug delivery to improve bioavailability. The research efforts are focused to “build-the–quality” within the drug products through pharmaceutical Quality by Design (QbD) concept. Using QbD, pharmaceutical quality is assured by understanding and controlling formulation and manufacturing variables. Dr. Patel guides students for major research programs like M.S. (Industrial Pharmacy) and Ph.D. He teaches various courses in both the graduate and entry-level programs.

 Biography
Research Interest :

He is actively involved in research areas of pharmaceutics like – (i) Pre-formulation profiling (physico-chemical characterization, solubility, permeability), (ii) Pharmaceutical material characterization (amorphous, polymorphism, pseudo-polymorphism, salt, co-crystals), (iii) Manufacturing sciences (mechanical property, tableting, granulation, flow property) and (iv) Drug delivery to improve bioavailability. The research efforts are focused to “build-the–quality” within the drug products through pharmaceutical Quality by Design (QbD) concept. Using QbD, pharmaceutical quality is assured by understanding and controlling formulation and manufacturing variables.

 Research Interest
 Network
Srinivasan Shanmugam

Srinivasan Shanmugam
Project Leader,
Formulation R&D,
Hanmi Pharm. Co. Ltd.,
South Korea

Biography :

Dr. Srinivasan Shanmugam received his Ph.D. in Pharmaceutical Science from the College of Pharmacy, Yeungnam University in 2010. During his doctoral studies, his research was on liposomes, niosomes, and chemical enhancers for topical delivery and self-emulsifying drug delivery systems (SNEDDS) for oral delivery. He received his MS in Pharmaceutical Sciences in the same university in the year of 2007, and his research focus during this period was on mixed micellar nanoparticles for parenteral and liposomes for topical delivery. His undergraduate major was Pharmacy (Bachelor of Phramacy) and received his degree in the year of 1999 with research focus on “Endothelin Receptors.” Right after undergraduate degree, he gained hands on experience in manufacturing of solid/liquid dosage formulations by working in pharmaceutical companies for about five years. Currently, Dr. Shanmugam is a Project Leader (Principal Scientist) in Formulation R&D Division of Hanmi Pharm. Co. Ltd., South Korea. His research focuses on design and development of conventional, NDDS/alternate/advanced, and modified drug delivery systems, and platform technologies. He has successfully designed, developed, and implemented various platform technologies to enhance oral bioavailability of highly hydrophilic drugs, poorly bioavailable highly lipophilic drugs, etc. Dr. Shanmugam has published numerous research articles in prestigious pharmaceutical sciences journals and presented more than 20 of his work in various symposiums/conferences globally. He is also a reviewer and editorial member of various journals.

 Biography
Research Interest :

His research interests include but not limited to the following; Drug Delivery Systems:  Conventional systems (tablets, capsules, emulsions, and suspensions)  Novel delivery systems (lipid formulations, micro/nano emulsions/self-emulsifying, micelles, liposomes/niosomes/cubosomes, multiparticulate, and pulsatile/targeted delivery ssytems). Drug Delivery Techniques:  Dissolution/solubility/stability enhancement  Bioavailability enhancement (oral/lymphatic/transdermal)  Perrmeability enhancement (oral/topical/transdermal) Drug Delivery Technologies:  Modified release (sustained/delayed/controlled/pulsatile/targeted)  Spray/freeze drying, and fluid bed drying

 Research Interest
 Network
 Acceptance Letter
Jayanthi Repalli

Jayanthi Repalli
NYU Langone Medical Center
New York
USA

 

Biography :
 Biography
Research Interest :

Extensive experience in the areas of drug discovery and design for cancer and neurodegenerative diseases

 Research Interest
 Network
 Acceptance Letter
Vikas Bhat

Vikas Bhat
Department of Medicine
University of California
USA
 

Biography :
 Biography
Research Interest :

Leading a collaborative interdisciplinary project to develop and test protein based drug molecules for the treatment of various bleeding complications associated with hemophilia patients or patients using various anticoagulants. Cloning and purification of recombinant protein using mammalian cells. Develop and optimize in-vitro assays for physicochemical characterization of potential protein drug candidates. Conduct both enzyme-based and ligand binding in-vitro assays and provide support for drug discovery programs throughout the lead optimization process. Develop novel drug delivery systems in different mice models and analysis of results thereof. Validate the successful candidates in different cell and mouse models. Conduct in vivo pharmacokinetic and metabolism studies of potential drug candidates in animals, integrate results with in vitro and biological findings and report data.

 Research Interest
 Network
Vural Fidan

Vural Fidan
Department of Medicine
Hacettepe University
Turkey

Biography :

Dr Vural Fidan has recieved his MD and PhD in Hacettepe University. He is deputy director of ENT department. He is an Otorhinolaryngologist at Yunus Emre Goverment Hospital. He worked as a visiting scientist at Yale University ENT and Allegry departments. He has more than 20 SCI indexed articles. Research interests are pulmonary hypertension, allergy, otology, rhinology and sleep medicine.

 Biography
Research Interest :

Research interests are pulmonary hypertension, allergy, otology, rhinology and sleep medicine

 Research Interest
 Network
 Acceptance Letter
Raktim Kumar Ghosh

Raktim Kumar Ghosh
Department of Internal Medicine
Case Western Reserve University
USA

Biography :

Dr. Ghosh is currently serving as chief resident in the Department of Internal Medicine, St. Vincent Charity Medical Center, An Affiliate of Case Western Reserve University, Cleveland, OH, USA. He finished a residency in Clinical Pharmacology from a premier medical institute in India, followed a clinical research fellowship from Outcomes Research, Cleveland Clinic, OH. Dr. Ghosh has published more than 20 original articles, review and case reports in high index journals. He has currently serving as reviewer and editorial member of various journals. He is current member of ASCO, ACP and SGIM societies and presented in various internal medicine meetings in USA. His research interests include newer drug development in oncology, diabetes and thrombosis.

 Biography
Research Interest :

His research interests include newer drug development in oncology, diabetes and thrombosis.

 Research Interest
 Network
Varun khurana

Varun Khurana
Formulation Scientist
INSYS Therapeutics.INC
Chandler
AZ, USA

Biography :

Dr. Varun Khurana obtained his Bachelors in Pharmacy from Guru Gobind Singh Indraprastha University, Delhi,, India. Dr. Khurana graduated with a Ph.D. in Pharmaceutical Sciences and Chemistry from reputed University of Missouri Kansas City, Kansas City, MO, USA. Currently, he is working as Formulations Scientist at Insys Therapeutics, Inc., USA, a specialty pharmaceutical company that develops and commercializes innovative supportive care products. Dr. Khurana’s research experience encompasses both industry and academia. Dr. Khurana worked on National Institutes of Health (NIH) funded research projects. Dr. Khurana’s research was focused on understanding the role of drug transporters (influx as well as efflux) in disposition of various anti-cancer drugs. He not only studied the alteration of drug pharmacokinetics via drug transporters in liver but also how the modulation affects brain as well plasma pharmacokinetics of anti-cancer drugs. Furthermore, his research work was focused on ocular drug delivery through nanoparticles. His research has been published in several peer-reviewed journals and books in the field of pharmaceutical sciences. Dr. Khurana’s current research at Insys Therapeutics is focused on development of oral solutions and sublingual sprays for new product development.

 Biography
Research Interest :

Novel Drug Delivery Systems, Solubility and Bioavailability Enhancement, Targeted Drug Delivery, Cancer Therapy, Targeted Delivery, Gene Therapy, Nanotechnology, Novel Drug Delivery Systems, Formulation Development (Oral solids, Liquid and Parenterals), Controlled or Modified Release.

 Research Interest
 Network
 Acceptance Letter
Alex Chang ZOU

Alex Chang ZOU
School of Biomedical Sciences
The Chinese University of Hong Kong
China

Biography :

Alex Chang ZOU, is a qualified physician and treated both emergency and in-hospital patients with surgical disorders as in Dong Rui Hospital, Nanjing, China. He is presently working as Deputy Director in Clinical Research Centre. His previous research work includes: 1. Selection and validation of esophageal cancer cell targeting phage-displayed peptides. 2. Dose-effect curve study and new applications development of human recombinant endostatin. 3. Preclinical study of an anti-VEGF monoclonal antibody drug. Functional study of estrogen-related receptor alpha in prostate cancer. 4. Estrogen-related receptor alpha in Castration-Resistance Prostate Cancer. He also provided an original idea and prepared preliminary data for the grant applying and found that ERR overexpression in prostate cancer contribute to its Bicalutamide-resistance and androgen independent growth both in vitro and in vivo.

 Biography
Research Interest :

Molecular cloning techniques; protein-protein interaction analysis: Co-IP, FRET, phage-displayed peptide library screening and identification (in vivo and in vitro); tumor angiogenesis analysis (in vitro and in vivo); histology techniques (slices and IHC); tissue culturing; construction and identification of sub-cell line by both transfection and infection; polyclonal antibody production in rabbit and purification, animal handling: tumor xenograft model constructing in mice subcutaneously and orthotopic, drug administration in mice by garage, i.p. and i.v. by tail vein.

 Research Interest
 Network
 Acceptance Letter
 
 
 
OMICS International Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
 
 
OMICS International Conferences 2016-17
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings
 
 

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

agrifoodaquavet@omicsinc.com

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

clinical_biochem@omicsinc.com

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

business@omicsinc.com

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

chemicaleng_chemistry@omicsinc.com

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

environmentalsci@omicsinc.com

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

engineering@omicsinc.com

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

generalsci_healthcare@omicsinc.com

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

genetics_molbio@omicsinc.com

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

immuno_microbio@omicsinc.com

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

omics@omicsinc.com

1-702-714-7001Extn: 9039

Materials Science Journals

Rachle Green

materialsci@omicsinc.com

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

mathematics_physics@omicsinc.com

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

medical@omicsinc.com

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

neuro_psychology@omicsinc.com

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

pharma@omicsinc.com

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

social_politicalsci@omicsinc.com

1-702-714-7001 Extn: 9042

 
© 2008-2016 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version